syndrome	score	normalized_score
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	1.01726602	100.0
TRICARBOXYLIC ACID CYCLE, DEFECT OF	1.0172414	99.99757978743848
SENGERS SYNDROME	1.00684932	98.97601022788511
OCULOSKELETODENTAL SYNDROME; OCSKD	1.0021768739999999	98.51669615387328
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	98.30270355437605
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.0	98.30270355437605
PITUITARY DERMOID AND EPIDERMOID CYSTS	1.0	98.30270355437605
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.933333	91.74915721651648
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.546756484	53.74764056308495
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.5104167	50.1753415493029
BARTH SYNDROME; BTHS	0.50344828	49.49032702380051
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.50075643	49.225710891237675
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.500545554	49.204981210322934
GLYCINE ENCEPHALOPATHY	0.5	49.151351777188026
RENAL TUBULAR ACIDOSIS III	0.5	49.151351777188026
179830 RENAL TUBULAR ACIDOSIS, PROXIMAL;;RENAL TUBULAR ACIDOSIS II;;RTA, PROXIMAL TYPE;;RTA, RATE TYPE	0.47878750000000003	47.066105678040834
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.458151304	45.03751182016282
GLUTATHIONE SYNTHETASE DEFICIENCY	0.3505744	34.46241131695326
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.34999969999999997	34.40591675322055
ACUTE ADRENAL INSUFFICIENCY	0.3470316	34.11414449880081
ACITRETIN/ETRETINATE EMBRYOPATHY	0.33572074999999996	33.00225736430279
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.333878554	32.82116451702574
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.333878554	32.82116451702574
EPIDERMAL NEVUS SYNDROME	0.333878554	32.82116451702574
GLUTATHIONE SYNTHETASE DEFICIENCY	0.333333	32.767535083890834
PSEUDOHYPOALDOSTERONISM, TYPE II	0.333333	32.767535083890834
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.333333	32.767535083890834
CYSTINOSIS, NEPHROPATHIC; CTNS	0.333333	32.767535083890834
NEUROMYELITIS OPTICA	0.333333	32.767535083890834
SPINOCEREBELLAR ATAXIA TYPE 42	0.333333	32.767535083890834
PLACENTAL INSUFFICIENCY	0.333333	32.767535083890834
ADDISON DISEASE	0.333333	32.767535083890834
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.32152769999999997	31.607042177620357
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.30000000000000004	29.490811066312823
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.27446538	26.980688886079175
HSD10 DISEASE	0.259060604	25.46635775762961
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.25661416	25.225865698335227
BIOTINIDASE DEFICIENCY	0.250545554	24.62930532172892
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.250545554	24.62930532172892
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.250545554	24.62930532172892
LACTIC ACIDOSIS, CHRONIC ADULT FORM	0.25	24.575675888594013
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.25	24.575675888594013
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.23571430000000002	23.171352956427267
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.22272730000000002	21.894695745366587
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6	0.21389157	21.026119598490077
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.20740741000000001	20.388709140210935
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.207394874	20.387476817519175
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.20667832400000002	20.317038015287288
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.20592189400000002	20.242678901237653
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.20075643	19.734899824924852
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.20054555400000001	19.71417014401012
SHOX-RELATED SHORT STATURE	0.2	19.660540710875214
POLYARTERITIS NODOSA	0.2	19.660540710875214
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	19.660540710875214
MEDULLARY SPONGE KIDNEY	0.2	19.660540710875214
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.2	19.660540710875214
BENIGN SCHWANNOMA	0.2	19.660540710875214
MALARIA	0.2	19.660540710875214
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.2	19.660540710875214
ALPHA-METHYLACETOACETIC ACIDURIA	0.2	19.660540710875214
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.2	19.660540710875214
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.180390374	17.732861459385028
MUCOLIPIDOSIS TYPE II	0.17570573	17.27234828899524
CEREBROOCULONASAL SYNDROME	0.16829832	16.54417985965952
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.166667	16.383816693297195
DERMATOLEUKODYSTROPHY	0.166667	16.383816693297195
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	16.383816693297195
GITELMAN SYNDROME	0.14545450000000001	14.298570594149995
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.13837935	13.603064221097249
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.13311061400000002	13.08513322798298
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.1266234	12.447422553247181
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.1266234	12.447422553247181
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.1266234	12.447422553247181
PULMONARY ARTERIOVENOUS MALFORMATION	0.1266234	12.447422553247181
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	0.1266234	12.447422553247181
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.1243902	12.22789295566955
OCULOCEREBRORENAL SYNDROME OF LOWE	0.12351602	12.141958698276385
GALACTOSEMIA	0.12152769999999999	11.946501466745147
PSEUDOHYPOALDOSTERONISM, TYPE IIC	0.12152769999999999	11.946501466745147
PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	0.12152769999999999	11.946501466745147
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.11796991400000002	11.596761484277241
PYRUVATE CARBOXYLASE DEFICIENCY	0.11443712400000002	11.249478676187376
ENTERIC ANENDOCRINOSIS	0.11111099999999999	10.922511694630277
NEPHROPATHIC INFANTILE CYSTINOSIS	0.11111099999999999	10.922511694630277
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.11111099999999999	10.922511694630277
ADULT ACUTE RESPIRATORY DISTRESS SYNDROME	0.1104167	10.854260127552475
FAMILIAL HYPOALDOSTERONISM	0.1104167	10.854260127552475
MELAS	0.10229164000000002	10.055544763010959
SAY SYNDROME	0.10075643000000001	9.904629469487244
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.10054555400000001	9.883899788572512
RABSON-MENDENHALL SYNDROME	0.10054555400000001	9.883899788572512
X-LINKED ACROGIGANTISM	0.1	9.830270355437607
INSULIN-RESISTANCE SYNDROME TYPE B	0.1	9.830270355437607
LOWE OCULOCEREBRORENAL SYNDROME	0.1	9.830270355437607
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.1	9.830270355437607
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.1	9.830270355437607
HUNTINGTON DISEASE-LIKE 1	0.09599150000000001	9.43622396823989
SALT-AND-PEPPER SYNDROME	0.09567534400000001	9.405144978694953
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.09512501000000001	9.35104565863706
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.09503851400000002	9.34254286799042
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.0945378	9.293321328082895
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.09449296000000001	9.288913434855516
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.09330630000000001	9.17226154865568
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.09157110000000002	9.001686697448127
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.091520524	8.99671493991316
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.0910816	8.95356752405826
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.09092110400000002	8.937790333348596
MALIGNANT ATROPHIC PAPULOSIS	0.0909091	8.93661030769513
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.0909091	8.93661030769513
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.0909091	8.93661030769513
ARTERIAL TORTUOSITY SYNDROME	0.0909091	8.93661030769513
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.09037555000000001	8.884160900213693
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.09037555000000001	8.884160900213693
HISTIOCYTOID CARDIOMYOPATHY	0.09037555000000001	8.884160900213693
ETHYLMALONIC ENCEPHALOPATHY	0.08827569	8.677738985128
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.08818919400000001	8.66923619448136
ADNP SYNDROME	0.08639897999999999	8.493253318340464
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.08551017400000002	8.405881285605117
RFT1-CDG	0.08463528400000002	8.319877233292429
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.08463528400000002	8.319877233292429
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.08463528400000002	8.319877233292429
BETA-KETOTHIOLASE DEFICIENCY	0.08393272	8.25081329267245
PETTIGREW SYNDROME	0.08387885400000002	8.245518119242792
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.08387885400000002	8.245518119242792
PERIPARTUM CARDIOMYOPATHY	0.08333330000000001	8.19188868610789
STORMORKEN SYNDROME; STRMK	0.08333330000000001	8.19188868610789
SPEECH-LANGUAGE DISORDER 1	0.08333330000000001	8.19188868610789
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.08333330000000001	8.19188868610789
RAVINE SYNDROME	0.08333330000000001	8.19188868610789
INHERITED CREUTZFELDT-JAKOB DISEASE	0.08333330000000001	8.19188868610789
DPM3-CDG	0.08333330000000001	8.19188868610789
TRISOMY 8P	0.07767953000000001	7.6361078098332635
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.077628954	7.631136052298296
GLYCEROL KINASE DEFICIENCY; GKD	0.077628954	7.631136052298296
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	7.561748695783627
BECKWITH-WIEDEMANN SYNDROME	0.07692310000000001	7.561748695783627
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.07692310000000001	7.561748695783627
DDOST-CDG	0.07692310000000001	7.561748695783627
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	7.561748695783627
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.07692310000000001	7.561748695783627
TRICHOHEPATOENTERIC SYNDROME 1	0.07692310000000001	7.561748695783627
CONGENITAL ENTEROVIRUS INFECTION	0.07692310000000001	7.561748695783627
TUBEROUS SCLEROSIS COMPLEX	0.07692310000000001	7.561748695783627
17Q23.1Q23.2 MICRODELETION SYNDROME	0.07631254999999999	7.5017299801285
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.074254504	7.299418494289231
LYSOSOMAL ACID LIPASE DEFICIENCY	0.07306765400000001	7.182747930575721
WOLCOTT-RALLISON SYNDROME	0.07250273	7.1272143740729685
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.07036015000000001	6.916592967491433
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.069686784	6.850399269209836
YOU-HOOVER-FONG SYNDROME; YHFS	0.069274384	6.809859234264011
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.067968684	6.681505394233063
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.067212254	6.607146280183426
XP21 MICRODELETION SYNDROME	0.067212254	6.607146280183426
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.067212254	6.607146280183426
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.0666667	6.553516847048522
DIABETES MELLITUS, KETOSIS-PRONE; KPD	0.0666667	6.553516847048522
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.06623091	6.510677511866561
X-LINKED ADRENOLEUKODYSTROPHY	0.06605965999999999	6.493843173882874
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.062686764	6.162278378275134
HUNTINGTON DISEASE-LIKE 2	0.06227178	6.121484329143325
VON HIPPEL-LINDAU DISEASE	0.06227178	6.121484329143325
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.061000373999999996	5.996501682028069
VICI SYNDROME; VICIS	0.060125484	5.9104976297153815
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.060125484	5.9104976297153815
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.060125484	5.9104976297153815
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.059891624	5.887508559462154
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.05957993	5.856868196580478
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.05957993	5.856868196580478
BILATERAL POLYMICROGYRIA	0.059369054	5.836138515665744
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.059369054	5.836138515665744
ALAGILLE SYNDROME 1; ALGS1	0.0591531	5.814909653622363
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.0588235	5.78250908253084
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.0588235	5.78250908253084
ACQUIRED METHEMOGLOBINEMIA	0.0588235	5.78250908253084
TIGLIC ACIDEMIA	0.0588235	5.78250908253084
3M SYNDROME	0.0588235	5.78250908253084
CEREBRAL ARTERIOVENOUS MALFORMATION	0.0588235	5.78250908253084
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 4	0.0588235	5.78250908253084
MULTIFOCAL MOTOR NEUROPATHY	0.0588235	5.78250908253084
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.0588235	5.78250908253084
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.0588235	5.78250908253084
SEVERE HEREDITARY THROMBOPHILIA DUE TO CONGENITAL PROTEIN C DEFICIENCY	0.0588235	5.78250908253084
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.0588235	5.78250908253084
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.0588235	5.78250908253084
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.0588235	5.78250908253084
LYMPHEDEMA-CEREBRAL ARTERIOVENOUS ANOMALY SYNDROME	0.0588235	5.78250908253084
SEVERE HEREDITARY THROMBOPHILIA DUE TO CONGENITAL PROTEIN S DEFICIENCY	0.0588235	5.78250908253084
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	0.0588235	5.78250908253084
GAPO SYNDROME	0.0588235	5.78250908253084
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.0588235	5.78250908253084
PSEUDOXANTHOMA ELASTICUM	0.0588235	5.78250908253084
VEIN OF GALEN ANEURYSMAL MALFORMATION	0.0588235	5.78250908253084
SPINOCEREBELLAR ATAXIA TYPE 40	0.0588235	5.78250908253084
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.0588235	5.78250908253084
BUTYRYLCHOLINESTERASE	0.0588235	5.78250908253084
ATYPICAL WERNER SYNDROME	0.0588235	5.78250908253084
MOYAMOYA DISEASE	0.0588235	5.78250908253084
FANCONI RENOTUBULAR SYNDROME 1; FRTS1	0.0588235	5.78250908253084
WERNER SYNDROME	0.0588235	5.78250908253084
NOCARDIOSIS	0.0588235	5.78250908253084
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.0588235	5.78250908253084
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.0588235	5.78250908253084
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.0588235	5.78250908253084
LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY	0.0588235	5.78250908253084
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.05863523999999999	5.764002615559693
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.058482054	5.748944017613013
JUVENILE POLYPOSIS SYNDROME	0.0579365	5.695314584478109
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.05776971	5.678918676552275
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.057173184	5.620278558011797
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.057173184	5.620278558011797
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.057159714	5.618954420594919
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.0566483	5.568681041759362
HYDROXYKYNURENINURIA	0.056416754	5.54591944396216
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.05536529999999999	5.4425586730990965
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.05520688	5.426985558802013
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.05445045	5.352626444752376
KEARNS-SAYRE SYNDROME; KSS	0.053253180000000004	5.234931566867829
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.053137430000000006	5.223553028931409
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.052826359999999996	5.192974006936749
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.050907854	5.004379680351458
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.050362300000000006	4.950750247216554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.050310394	4.94564774708586
AICARDI SYNDROME	0.04983053999999999	4.8984768015744775
ERYTHERMALGIA, PRIMARY	0.0494995	4.865934674589838
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.04907410999999999	4.824117687524841
AMISH INFANTILE EPILEPSY SYNDROME	0.04763039000000001	4.682196108349319
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O	0.047141	4.634087748256841
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.047141	4.634087748256841
VICI SYNDROME	0.046000054	4.521929671847291
HAMAMY SYNDROME; HMMS	0.04597704	4.51966733342769
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.04550946000000001	4.4737029552997365
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	0.0454545	4.468300238712387
ALAGILLE SYNDROME 2	0.0454545	4.468300238712387
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.0454545	4.468300238712387
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.0454545	4.468300238712387
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.0454545	4.468300238712387
RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT	0.0454545	4.468300238712387
OSTEOPETROSIS AND RELATED DISORDERS	0.0454545	4.468300238712387
XQ12-Q13.3 DUPLICATION SYNDROME	0.044054449999999995	4.330671538601083
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.04387814	4.3133397889374105
49,XXXYY SYNDROME	0.04329801999999999	4.256312424551445
HYDROXYKYNURENINURIA	0.043220353999999996	4.248677646777192
LISSENCEPHALY, X-LINKED, 2	0.04312171000000001	4.238980674887775
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.042555699999999995	4.183340361648961
XP22.13P22.2 DUPLICATION SYNDROME	0.042423129999999996	4.1703083722387575
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.042423129999999996	4.1703083722387575
DISTAL 17P13.1 MICRODELETION SYNDROME	0.042423129999999996	4.1703083722387575
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.042423129999999996	4.1703083722387575
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.042423129999999996	4.1703083722387575
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.042423129999999996	4.1703083722387575
NON-DISTAL MONOSOMY 20Q	0.042053259999999995	4.1339491512751
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.041666699999999994	4.09594925818912
HISTIDINEMIA	0.041666699999999994	4.09594925818912
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.041666699999999994	4.09594925818912
PGM3-CDG	0.041666699999999994	4.09594925818912
49,XYYYY SYNDROME	0.041666699999999994	4.09594925818912
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.041655960000000006	4.094893487152947
ACRORENAL-MANDIBULAR SYNDROME	0.04102532	4.032899870183416
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.04042194	3.973585984912776
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.040421939999999996	3.9735859849127753
NEURONAL CEROID LIPOFUSCINOSIS	0.04035632	3.9671353615055382
FABRY DISEASE	0.04002464000000001	3.934530320790623
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.039968699999999996	3.9290312675537904
WILLIAMS-BEUREN SYNDROME; WBS	0.03972012	3.9045951815042432
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.03916258	3.849787492164537
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.03916258	3.849787492164537
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.038888900000000004	3.822884008255776
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.038647604	3.799163959098919
ZELLWEGER SYNDROME	0.038102050000000005	3.745534525964015
OCULOECTODERMAL SYNDROME; OES	0.037891174	3.7248048450492814
VASCULAR EHLERS-DANLOS SYNDROME	0.037891174	3.7248048450492814
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.03763444	3.699567198754952
OCULODENTODIGITAL DYSPLASIA	0.037337699999999995	3.6703968545022265
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.037324869999999996	3.669135630815624
ATYPICAL RETT SYNDROME	0.037324869999999996	3.669135630815624
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.037016284	3.638800792736594
PYRIDOXINE-DEPENDENT EPILEPSY	0.036591533999999995	3.5970467194018716
HUNTINGTON DISEASE	0.03656844	3.5947765167659878
FLYNN-AIRD SYNDROME	0.03656844	3.5947765167659878
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.03647073000000001	3.58517135960169
MICROHYDRANENCEPHALY; MHAC	0.03647073000000001	3.58517135960169
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.03647073000000001	3.58517135960169
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.03647073000000001	3.58517135960169
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.03604598	3.5434172862669686
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.03604598	3.5434172862669686
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.036002320000000004	3.5391253902297843
BRAIN-LUNG-THYROID SYNDROME	0.035784784	3.51774101330938
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.035714300000000004	3.510812245552054
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.035714300000000004	3.510812245552054
SCHINZEL-GIEDION SYNDROME	0.035714300000000004	3.510812245552054
FAMILIAL THROMBOCYTOSIS	0.035714300000000004	3.510812245552054
FAMILIAL CERVICAL ARTERY DISSECTION	0.035714300000000004	3.510812245552054
ESSENTIAL THROMBOCYTHEMIA	0.035714300000000004	3.510812245552054
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.035714300000000004	3.510812245552054
HYPOALPHALIPOPROTEINEMIA	0.035714300000000004	3.510812245552054
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.035714300000000004	3.510812245552054
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.035714300000000004	3.510812245552054
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.035714300000000004	3.510812245552054
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.035714300000000004	3.510812245552054
PARTIAL ATRIOVENTRICULAR CANAL	0.035714300000000004	3.510812245552054
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.035714300000000004	3.510812245552054
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.035714300000000004	3.510812245552054
SLC39A8-CDG	0.035714300000000004	3.510812245552054
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.035714300000000004	3.510812245552054
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.035714300000000004	3.510812245552054
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.035714300000000004	3.510812245552054
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.035714300000000004	3.510812245552054
SPINOCEREBELLAR ATAXIA TYPE 34	0.035706379999999996	3.510033688139902
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.035191403999999996	3.4594101550742837
WOLF-HIRSCHHORN SYNDROME	0.035191403999999996	3.4594101550742837
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.035028354	3.4433818992597427
PROGRESSIVE SUPRANUCLEAR PALSY	0.0344828	3.389752466124839
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.0344828	3.389752466124839
PRKAR1B-RELATED NEURODEGENERATIVE DEMENTIA WITH INTERMEDIATE FILAMENTS	0.0344828	3.389752466124839
BECKER MUSCULAR DYSTROPHY	0.0344828	3.389752466124839
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.0344828	3.389752466124839
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.0344828	3.389752466124839
RICHIERI COSTA-DA SILVA SYNDROME	0.0344828	3.389752466124839
PERIORAL MYOCLONIA WITH ABSENCES	0.0344828	3.389752466124839
HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE	0.0344828	3.389752466124839
PROGRESSIVE SUPRANUCLEAR PALSY-PURE AKINESIA WITH GAIT FREEZING SYNDROME	0.0344828	3.389752466124839
LENNOX-GASTAUT SYNDROME	0.0344828	3.389752466124839
FRIEDREICH ATAXIA	0.0344828	3.389752466124839
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.0344828	3.389752466124839
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY	0.0344828	3.389752466124839
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.0344828	3.389752466124839
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.0344828	3.389752466124839
MYOPATHY, TUBULAR AGGREGATE, 2; TAM2	0.0344828	3.389752466124839
SPINOCEREBELLAR ATAXIA TYPE 37	0.0344828	3.389752466124839
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.0344828	3.389752466124839
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.0344828	3.389752466124839
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.0344828	3.389752466124839
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.0344828	3.389752466124839
GIANT AXONAL NEUROPATHY	0.0344828	3.389752466124839
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.033889419999999996	3.331421607889743
9P13 MICRODELETION SYNDROME	0.033889419999999996	3.331421607889743
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.033889419999999996	3.331421607889743
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.033560084	3.2990469887119587
MEIER-GORLIN SYNDROME 5; MGORS5	0.03301453	3.245417555577055
ISOTRETINOIN-LIKE SYNDROME	0.03301453	3.245417555577055
ISOLATED CEREBELLAR AGENESIS	0.03301453	3.245417555577055
SECKEL SYNDROME	0.03301453	3.245417555577055
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.03301453	3.245417555577055
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.03301453	3.245417555577055
SECKEL SYNDROME 2; SCKL2	0.03301453	3.245417555577055
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.032803653999999995	3.224687874662322
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.032803653999999995	3.224687874662322
GRISCELLI SYNDROME TYPE 1	0.032803653999999995	3.224687874662322
SARCOSINEMIA	0.032803653999999995	3.224687874662322
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.032803653999999995	3.224687874662322
OXOGLUTARIC ACIDURIA	0.032803653999999995	3.224687874662322
NETHERTON SYNDROME; NETH	0.032803653999999995	3.224687874662322
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.032803653999999995	3.224687874662322
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.032803653999999995	3.224687874662322
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.032541504	3.1989178209255424
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0322581	3.171058441527418
INFANTILE MYOFIBROMATOSIS	0.0322581	3.171058441527418
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	3.171058441527418
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.0322581	3.171058441527418
DENT DISEASE	0.0322581	3.171058441527418
ROWLEY-ROSENBERG SYNDROME	0.0322581	3.171058441527418
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.0322581	3.171058441527418
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.0322581	3.171058441527418
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0322581	3.171058441527418
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0322581	3.171058441527418
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	3.171058441527418
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0322581	3.171058441527418
PROGRESSIVE HEMIFACIAL ATROPHY	0.0322581	3.171058441527418
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.0322581	3.171058441527418
THROMBOCYTOPENIA 1	0.0322581	3.171058441527418
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.0322581	3.171058441527418
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	3.171058441527418
SANDHOFF DISEASE	0.0322581	3.171058441527418
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0322581	3.171058441527418
DIENCEPHALIC SYNDROME	0.0322581	3.171058441527418
MILD CANAVAN DISEASE	0.0322581	3.171058441527418
COG1-CDG	0.0322581	3.171058441527418
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.0322581	3.171058441527418
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.0322581	3.171058441527418
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0322581	3.171058441527418
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.0322581	3.171058441527418
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0322581	3.171058441527418
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	3.171058441527418
LESCH-NYHAN SYNDROME	0.0322581	3.171058441527418
DESMOID TUMOR	0.0322581	3.171058441527418
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.0322581	3.171058441527418
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	3.171058441527418
LEIGH SYNDROME	0.0322581	3.171058441527418
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0322581	3.171058441527418
DEND SYNDROME	0.0322581	3.171058441527418
CONGENITAL ANALBUMINEMIA	0.0322581	3.171058441527418
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0322581	3.171058441527418
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0322581	3.171058441527418
HSD10 DISEASE, ATYPICAL TYPE	0.0322581	3.171058441527418
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0322581	3.171058441527418
DYSTONIA, JUVENILE-ONSET	0.0322581	3.171058441527418
MERRF	0.0322581	3.171058441527418
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.030531844	3.0013628097004554
AL KAISSI SYNDROME; ALKAS	0.030531844	3.0013628097004554
COFFIN-LOWRY SYNDROME	0.029910139999999998	2.9402476256898855
TRISOMY 20P	0.0294698	2.896961013206752
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.02937504	2.887645849017939
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 4; CEMCOX4	0.02926445	2.8767745530318605
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.029058534	2.8565324535267576
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.028900524	2.840999643338131
DRAVET SYNDROME	0.02870054	2.8213406754705126
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.02870054	2.8213406754705126
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.028407544	2.7925383765398943
SPINOCEREBELLAR ATAXIA TYPE 5	0.027838480000000002	2.736597846844427
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.026972464	2.6514661327230806
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.026567074	2.611615199729172
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.026567074	2.611615199729172
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.026216034000000003	2.577107018673444
DOWN SYNDROME	0.02605664	2.561438157543097
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.025692184	2.5256111474164835
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.025692184	2.5256111474164835
FETAL HYDANTOIN SYNDROME	0.025660603999999997	2.522506748038236
PHELAN-MCDERMID SYNDROME	0.025155504	2.472854052472921
PITT-HOPKINS SYNDROME	0.02514663	2.4719817142815796
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.024935754	2.4512520333668473
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.024935754	2.4512520333668473
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.024935754	2.4512520333668473
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.024935754	2.4512520333668473
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.024935754	2.4512520333668473
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.024935754	2.4512520333668473
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.024935754	2.4512520333668473
SPINOCEREBELLAR ATAXIA 5; SCA5	0.024935754	2.4512520333668473
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.024935754	2.4512520333668473
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.024853824	2.443198092864637
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.024853824	2.443198092864637
MAN1B1-CDG	0.024399074	2.3984949384232843
CHROMOSOME 17P13.1 DELETION SYNDROME	0.024399074	2.3984949384232843
ADRENOLEUKODYSTROPHY	0.0243902	2.3976226002319434
HUNTINGTON DISEASE-LIKE 1	0.0243902	2.3976226002319434
MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO	0.0243902	2.3976226002319434
EPISODIC ATAXIA, TYPE 1; EA1	0.0243902	2.3976226002319434
SPINOCEREBELLAR ATAXIA 26	0.0243902	2.3976226002319434
SPINOCEREBELLAR ATAXIA TYPE 6	0.0243902	2.3976226002319434
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.0243902	2.3976226002319434
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.0243902	2.3976226002319434
ORAL SENSIBILITY, DISTURBANCE OF	0.0243902	2.3976226002319434
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.0243902	2.3976226002319434
MILLER-DIEKER SYNDROME	0.024358619999999997	2.3945182008536956
CRANIOFACIOFRONTODIGITAL SYNDROME	0.024358619999999997	2.3945182008536956
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.02430827	2.3895686597297328
PRIMARY HYPEROXALURIA TYPE 1	0.0241153	2.370599187024845
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.024061574	2.3653177759736828
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.024029283999999998	2.3621435816759115
POTOCKI-LUPSKI SYNDROME	0.024029283999999998	2.3621435816759115
SCARF SYNDROME	0.02385352	2.3448655052883804
COFFIN-SIRIS SYNDROME 1; CSS1	0.023524184	2.3124908861105964
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.023524184	2.3124908861105964
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.023524184	2.3124908861105964
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.023524184	2.3124908861105964
KAGAMI-OGATA SYNDROME	0.023272854	2.2877844676262753
SILVER-RUSSELL SYNDROME; SRS	0.023272854	2.2877844676262753
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.02297863	2.258861452975692
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.02297863	2.258861452975692
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.02297863	2.258861452975692
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.02297863	2.258861452975692
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.02297863	2.258861452975692
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.02297863	2.258861452975692
2Q23.1 MICRODUPLICATION SYNDROME	0.022767754	2.2381317720609597
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.022767754	2.2381317720609597
TYSHCHENKO SYNDROME	0.022767754	2.2381317720609597
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.022767754	2.2381317720609597
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.022767754	2.2381317720609597
CHROMOSOME 5Q12 DELETION SYNDROME	0.022767754	2.2381317720609597
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.022767754	2.2381317720609597
YUNIS-VARON SYNDROME	0.022767754	2.2381317720609597
FG SYNDROME TYPE 1	0.022767754	2.2381317720609597
ARTERIES, ANOMALIES OF	0.0227273	2.234155034491371
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0227273	2.234155034491371
ATROPHODERMA VERMICULATA; AVA	0.0227273	2.234155034491371
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0227273	2.234155034491371
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0227273	2.234155034491371
FATCO SYNDROME	0.0227273	2.234155034491371
MUSCULAR HYPERTONIA, LETHAL	0.0227273	2.234155034491371
SILVER-RUSSELL SYNDROME	0.0227273	2.234155034491371
LARSEN SYNDROME	0.0227273	2.234155034491371
PREPAPILLARY VASCULAR LOOPS	0.0227273	2.234155034491371
COWDEN SYNDROME 6; CWS6	0.0227273	2.234155034491371
BETHLEM MYOPATHY 1	0.0227273	2.234155034491371
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0227273	2.234155034491371
WATSON SYNDROME	0.0227273	2.234155034491371
HEMANGIOPERICYTOMA, MALIGNANT	0.0227273	2.234155034491371
CONGENITAL ATRANSFERRINEMIA	0.0227273	2.234155034491371
HYPOADRENOCORTICISM, FAMILIAL	0.0227273	2.234155034491371
COWDEN SYNDROME 5; CWS5	0.0227273	2.234155034491371
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0227273	2.234155034491371
COCAINE EMBRYOFETOPATHY	0.0227273	2.234155034491371
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0227273	2.234155034491371
AMYLOIDOSIS	0.0227273	2.234155034491371
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.0227273	2.234155034491371
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.0227273	2.234155034491371
VENULAR INSUFFICIENCY, SYSTEMIC	0.0227273	2.234155034491371
THUMB DEFORMITY	0.0227273	2.234155034491371
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0227273	2.234155034491371
SIRENOMELIA	0.0227273	2.234155034491371
RHOMBENCEPHALOSYNAPSIS	0.0227273	2.234155034491371
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.0227273	2.234155034491371
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.02252572	2.2143391755088797
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.022314844	2.1936094945941473
RAPADILINO SYNDROME	0.0222222	2.184502338926056
SMITH-KINGSMORE SYNDROME; SKS	0.0222222	2.184502338926056
JUVENILE POLYPOSIS OF INFANCY	0.0222222	2.184502338926056
PERMANENT NEONATAL DIABETES MELLITUS-PANCREATIC AND CEREBELLAR AGENESIS SYNDROME	0.0222222	2.184502338926056
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.0222222	2.184502338926056
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.0222222	2.184502338926056
FRONTOMETAPHYSEAL DYSPLASIA	0.0222222	2.184502338926056
ALG13-CDG	0.0222222	2.184502338926056
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.0222222	2.184502338926056
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.022195744	2.1819016426008213
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.022195744	2.1819016426008213
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.02204304	2.1668904265572535
UNILATERAL POLYMICROGYRIA	0.021862439999999997	2.1491369582953332
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02102928	2.0672350778019695
GRANULOMAS, CONGENITAL CEREBRAL	0.02102928	2.0672350778019695
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02102928	2.0672350778019695
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02102928	2.0672350778019695
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02102928	2.0672350778019695
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.02075642	2.0404122021101223
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.020740849999999998	2.0388816290157803
WILLIAMS SYNDROME	0.02039669	2.0050497705605066
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.020392254	2.0046136997675394
KOOLEN-DE VRIES SYNDROME; KDVS	0.019600003999999997	1.926733382876585
TRISOMY 18	0.019600003999999997	1.926733382876585
DOORS SYNDROME	0.019600003999999997	1.926733382876585
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.019600003999999997	1.926733382876585
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.01950752	1.9176419556410622
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.01950752	1.9176419556410622
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.019503893999999997	1.9172855100379738
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.019503893999999997	1.9172855100379738
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.019481839999999997	1.9151175422137856
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.019054449999999997	1.8731039497416808
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.01889734	1.8576596119862527
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.018843574	1.8523742688269482
FUMARASE DEFICIENCY; FMRD	0.018760934	1.8442505334052148
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.018760934	1.8442505334052148
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.018747464	1.8429263959883373
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.018747464	1.8429263959883373
AMISH LETHAL MICROCEPHALY	0.01858054	1.8265173155002268
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.018580094000000002	1.8264734724944414
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.018568004	1.8252849928084687
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.018567069999999998	1.825193178083349
CEREBROOCULONASAL SYNDROME	0.018298019999999998	1.7987448356920441
NASODIGITOACOUSTIC SYNDROME	0.018298019999999998	1.7987448356920441
COSTELLO SYNDROME	0.018298019999999998	1.7987448356920441
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.018298019999999998	1.7987448356920441
SAETHRE-CHOTZEN SYNDROME	0.018298019999999998	1.7987448356920441
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.018298019999999998	1.7987448356920441
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.01820191	1.7892969628534334
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.018175320000000002	1.7866830939659226
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.018022450000000002	1.7716555596735653
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.018022450000000002	1.7716555596735653
PROPIONIC ACIDEMIA	0.018004504	1.7698914193555781
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.018004504	1.7698914193555781
BOHRING-OPITZ SYNDROME	0.017968684	1.76637021651426
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.017968684	1.76637021651426
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.017968684	1.76637021651426
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.017811574	1.7509258787588324
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.017811574	1.7509258787588324
PEARSON SYNDROME	0.01745895	1.716261986220674
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.01745895	1.716261986220674
COLCHICINE POISONING	0.01745895	1.716261986220674
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.01745895	1.716261986220674
COFFIN-LOWRY SYNDROME; CLS	0.01742313	1.712740783379356
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.01742313	1.712740783379356
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.01726602	1.6972964456239283
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.01726602	1.6972964456239283
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	0.01726602	1.6972964456239283
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.01726602	1.6972964456239283
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.01726602	1.6972964456239283
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.01726602	1.6972964456239283
ANDROSTENONE, ABILITY TO SMELL	0.0172414	1.6948762330624194
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	1.6948762330624194
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	1.6948762330624194
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	1.6948762330624194
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	1.6948762330624194
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	1.6948762330624194
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	1.6948762330624194
SPASTIC PSEUDOSCLEROSIS	0.0172414	1.6948762330624194
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	1.6948762330624194
MOTION SICKNESS	0.0172414	1.6948762330624194
DIASTEMATOMYELIA	0.0172414	1.6948762330624194
ALCOHOL DEPENDENCE	0.0172414	1.6948762330624194
TRANSSEXUALITY	0.0172414	1.6948762330624194
THUMBS, CONGENITAL CLASPED	0.0172414	1.6948762330624194
JUMPING FRENCHMAN OF MAINE	0.0172414	1.6948762330624194
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	1.6948762330624194
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	1.6948762330624194
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	1.6948762330624194
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	1.6948762330624194
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	1.6948762330624194
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	1.6948762330624194
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	1.6948762330624194
SICKLE CELL ANEMIA	0.0172414	1.6948762330624194
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	1.6948762330624194
ENDOCARDIAL FIBROELASTOSIS	0.0172414	1.6948762330624194
CONGENITAL TRACHEAL STENOSIS	0.0172414	1.6948762330624194
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	1.6948762330624194
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	1.6948762330624194
269800 SENILE PLAQUE FORMATION	0.0172414	1.6948762330624194
PALMOMENTAL REFLEX	0.0172414	1.6948762330624194
MOSAIC TRISOMY 15	0.0172414	1.6948762330624194
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	1.6948762330624194
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	1.6948762330624194
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	1.6948762330624194
RHEUMATOID ARTHRITIS	0.0172414	1.6948762330624194
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	1.6948762330624194
CERVICAL RIB	0.0172414	1.6948762330624194
CARDIAC ARRHYTHMIA	0.0172414	1.6948762330624194
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	1.6948762330624194
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	1.6948762330624194
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	1.6948762330624194
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	1.6948762330624194
MYOPATHY, CONGENITAL	0.0172414	1.6948762330624194
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	1.6948762330624194
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	1.6948762330624194
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.017212254	1.6920111024646234
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.017212254	1.6920111024646234
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.017212254	1.6920111024646234
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.017212254	1.6920111024646234
ALPHA-MANNOSIDOSIS	0.017212254	1.6920111024646234
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.01714688	1.6855846615224597
ABETA AMYLOIDOSIS, IOWA TYPE	0.01714688	1.6855846615224597
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.01696854	1.6680533573705727
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.01696854	1.6680533573705727
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.01696854	1.6680533573705727
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.0166667	1.6383816693297193
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.0166667	1.6383816693297193
MARFAN SYNDROME; MFS	0.0166667	1.6383816693297193
WEILL-MARCHESANI SYNDROME 2; WMS2	0.0166667	1.6383816693297193
WARBURG MICRO SYNDROME 3; WARBM3	0.0166667	1.6383816693297193
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.0166667	1.6383816693297193
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.0166667	1.6383816693297193
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.0166667	1.6383816693297193
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.0166667	1.6383816693297193
BÖÖK SYNDROME	0.0166667	1.6383816693297193
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.0166667	1.6383816693297193
PYCNODYSOSTOSIS	0.0166667	1.6383816693297193
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.0166667	1.6383816693297193
WEILL-MARCHESANI SYNDROME 1; WMS1	0.0166667	1.6383816693297193
CROUZON DISEASE	0.0166667	1.6383816693297193
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.0166667	1.6383816693297193
APERT SYNDROME	0.0166667	1.6383816693297193
RAMON SYNDROME	0.0166667	1.6383816693297193
RAMON SYNDROME	0.0166667	1.6383816693297193
PYCNODYSOSTOSIS	0.0166667	1.6383816693297193
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.016106480000000003	1.5833105287444873
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.016106480000000003	1.5833105287444873
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.016068444	1.5795714871120927
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.015558714	1.5294636500293204
NEONATAL ADRENOLEUKODYSTROPHY	0.01550563	1.5242453493138401
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.015346424	1.508594969091762
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.015272594	1.5013372804883427
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.015193554	1.4935674347994046
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.015193554	1.4935674347994046
CEDNIK SYNDROME	0.015000583999999999	1.4745979620945167
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.015000583999999999	1.4745979620945167
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.015000583999999999	1.4745979620945167
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.01472704	1.4477078473534384
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.014648	1.4399380016645005
LEIGH SYNDROME; LS	0.014437123999999999	1.4192083207497679
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.014437123999999999	1.4192083207497679
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.014437123999999999	1.4192083207497679
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.014437123999999999	1.4192083207497679
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.014437123999999999	1.4192083207497679
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.014437123999999999	1.4192083207497679
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.014437123999999999	1.4192083207497679
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.014437123999999999	1.4192083207497679
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.014437123999999999	1.4192083207497679
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.014437123999999999	1.4192083207497679
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.014437123999999999	1.4192083207497679
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.014437123999999999	1.4192083207497679
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.014437123999999999	1.4192083207497679
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.01441507	1.4170403529255797
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.014256729999999999	1.4014751028447796
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.014244153999999998	1.4002388480448797
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.014244153999999998	1.4002388480448797
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.014244153999999998	1.4002388480448797
ABETAL34V AMYLOIDOSIS	0.014244153999999998	1.4002388480448797
CITRULLINEMIA, CLASSIC	0.014244153999999998	1.4002388480448797
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.013960184000000002	1.372323829316544
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.013891569999999999	1.3655788876148638
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.013891569999999999	1.3655788876148638
LIVER FAILURE, INFANTILE, TRANSIENT	0.013891569999999999	1.3655788876148638
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.013891569999999999	1.3655788876148638
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.013891569999999999	1.3655788876148638
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.013891569999999999	1.3655788876148638
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.013891569999999999	1.3655788876148638
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.013891569999999999	1.3655788876148638
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.013891569999999999	1.3655788876148638
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.013698599999999998	1.3466094149099759
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.013698599999999998	1.3466094149099759
STROKE, ISCHEMIC	0.013698599999999998	1.3466094149099759
MOYAMOYA DISEASE WITH EARLY-ONSET ACHALASIA	0.013698599999999998	1.3466094149099759
ATRIAL FIBRILLATION, FAMILIAL, 1; ATFB1	0.013698599999999998	1.3466094149099759
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.013698599999999998	1.3466094149099759
HEPARIN-INDUCED THROMBOCYTOPENIA	0.013698599999999998	1.3466094149099759
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.013698599999999998	1.3466094149099759
SICKLE CELL ANEMIA	0.013698599999999998	1.3466094149099759
ACYS AMYLOIDOSIS	0.013698599999999998	1.3466094149099759
ABETA AMYLOIDOSIS, DUTCH TYPE	0.013698599999999998	1.3466094149099759
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.013698599999999998	1.3466094149099759
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.013698599999999998	1.3466094149099759
EISENMENGER SYNDROME	0.013698599999999998	1.3466094149099759
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.013698599999999998	1.3466094149099759
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.013698599999999998	1.3466094149099759
POLYCYTHEMIA VERA	0.013698599999999998	1.3466094149099759
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.013698599999999998	1.3466094149099759
PRADER-WILLI SYNDROME	0.013698599999999998	1.3466094149099759
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.013698599999999998	1.3466094149099759
AORTIC ANEURYSM, FAMILIAL THORACIC 4	0.013698599999999998	1.3466094149099759
AORTA COARCTATION	0.013698599999999998	1.3466094149099759
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.013698599999999998	1.3466094149099759
WALDENSTRÖM MACROGLOBULINEMIA	0.013698599999999998	1.3466094149099759
SNEDDON SYNDROME	0.013698599999999998	1.3466094149099759
APPARENT MINERALOCORTICOID EXCESS	0.013698599999999998	1.3466094149099759
FAMILIAL AORTIC DISSECTION	0.013698599999999998	1.3466094149099759
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.013698599999999998	1.3466094149099759
CARDIOMYOPATHY, DILATED, 1E	0.013698599999999998	1.3466094149099759
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.013698599999999998	1.3466094149099759
ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3	0.013698599999999998	1.3466094149099759
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.013698599999999998	1.3466094149099759
ANEURYSM OF SINUS OF VALSALVA	0.013698599999999998	1.3466094149099759
SECONDARY POLYCYTHEMIA	0.013698599999999998	1.3466094149099759
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.013698599999999998	1.3466094149099759
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.013698599999999998	1.3466094149099759
FIBROMUSCULAR DYSPLASIA OF ARTERIES	0.013698599999999998	1.3466094149099759
PSEUDOXANTHOMA ELASTICUM; PXE	0.013698599999999998	1.3466094149099759
%602248 MALIGNANT ATROPHIC PAPULOSIS;;DEGOS DISEASE;;PAPULOSIS, MALIGNANT ATROPHIC	0.013698599999999998	1.3466094149099759
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.013698599999999998	1.3466094149099759
AMYLOIDOSIS VI	0.013698599999999998	1.3466094149099759
STURGE-WEBER SYNDROME	0.013698599999999998	1.3466094149099759
WOLFF-PARKINSON-WHITE SYNDROME	0.013698599999999998	1.3466094149099759
DERMOGRAPHISM, FAMILIAL	0.013698599999999998	1.3466094149099759
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.01354018	1.3310363006128918
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.013414630000000002	1.31869439618164
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.013414630000000002	1.31869439618164
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.013414630000000002	1.31869439618164
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.013350004	1.3123414856617346
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.013203754000000002	1.2979647152669072
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.013203754000000002	1.2979647152669072
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.013203754000000002	1.2979647152669072
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.013203754000000002	1.2979647152669072
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.013203754000000002	1.2979647152669072
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.01313496	1.2912020790785874
8P INVERTED DUPLICATION/DELETION SYNDROME	0.01278375	1.2566771865632549
4Q21 MICRODELETION SYNDROME	0.01278375	1.2566771865632549
MYOPATHY, MYOFIBRILLAR, 9, WITH EARLY RESPIRATORY FAILURE; MFM9	0.012658200000000001	1.2443352821320033
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC; CMT2CC	0.012658200000000001	1.2443352821320033
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.012658200000000001	1.2443352821320033
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.012658200000000001	1.2443352821320033
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.012658200000000001	1.2443352821320033
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.012658200000000001	1.2443352821320033
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1G; CMT1G	0.012658200000000001	1.2443352821320033
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.012658200000000001	1.2443352821320033
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.012658200000000001	1.2443352821320033
MULTIPLE SYSTEM ATROPHY	0.012658200000000001	1.2443352821320033
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.012658200000000001	1.2443352821320033
ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	0.012658200000000001	1.2443352821320033
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.012658200000000001	1.2443352821320033
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.012658200000000001	1.2443352821320033
MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15	0.012658200000000001	1.2443352821320033
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.012658200000000001	1.2443352821320033
SPINOCEREBELLAR ATAXIA 37; SCA37	0.012658200000000001	1.2443352821320033
SPINOCEREBELLAR ATAXIA 44; SCA44	0.012658200000000001	1.2443352821320033
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 3	0.012658200000000001	1.2443352821320033
HEREDITARY MOTOR AND SENSORY NEUROPATHY V	0.012658200000000001	1.2443352821320033
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.012658200000000001	1.2443352821320033
STIFF-PERSON SYNDROME; SPS	0.012658200000000001	1.2443352821320033
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.012658200000000001	1.2443352821320033
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.012658200000000001	1.2443352821320033
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.012658200000000001	1.2443352821320033
CAP MYOPATHY	0.012658200000000001	1.2443352821320033
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.012658200000000001	1.2443352821320033
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.012658200000000001	1.2443352821320033
NEMALINE MYOPATHY 3; NEM3	0.012658200000000001	1.2443352821320033
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.012658200000000001	1.2443352821320033
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.012658200000000001	1.2443352821320033
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.012658200000000001	1.2443352821320033
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.012658200000000001	1.2443352821320033
EPISODIC ATAXIA TYPE 4	0.012658200000000001	1.2443352821320033
PRIMARY PROGRESSIVE FREEZING GAIT	0.012658200000000001	1.2443352821320033
ADENYLOSUCCINATE SYNTHETASE-LIKE 1-RELATED DISTAL MYOPATHY	0.012658200000000001	1.2443352821320033
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.012658200000000001	1.2443352821320033
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.012658200000000001	1.2443352821320033
ALPHA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R3	0.012658200000000001	1.2443352821320033
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.012658200000000001	1.2443352821320033
HYPEREKPLEXIA 1; HKPX1	0.012658200000000001	1.2443352821320033
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.012658200000000001	1.2443352821320033
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.012658200000000001	1.2443352821320033
X-LINKED DYSTONIA-PARKINSONISM	0.012658200000000001	1.2443352821320033
NEMALINE MYOPATHY 2; NEM2	0.012658200000000001	1.2443352821320033
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.012658200000000001	1.2443352821320033
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.012658200000000001	1.2443352821320033
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.012658200000000001	1.2443352821320033
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.012658200000000001	1.2443352821320033
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.012658200000000001	1.2443352821320033
MYOPATHY AND DIABETES MELLITUS	0.012658200000000001	1.2443352821320033
PURE MITOCHONDRIAL MYOPATHY	0.012658200000000001	1.2443352821320033
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.012658200000000001	1.2443352821320033
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.012654574	1.2439788365289148
TRISOMY XQ28	0.01248701	1.2275068423105293
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.01247418	1.2262456186239268
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.01247418	1.2262456186239268
CHRISTIANSON SYNDROME	0.01247418	1.2262456186239268
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.012461644000000001	1.2250132959321691
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.012461644000000001	1.2250132959321691
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.012461644000000001	1.2250132959321691
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.01210902	1.1903494033940107
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.01195172	1.1748863881249076
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.011951719999999999	1.1748863881249074
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.01191609	1.171383862797265
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.01191609	1.171383862797265
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.011898144	1.1696197224792781
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.011898144	1.1696197224792781
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.011898144	1.1696197224792781
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.011757924000000001	1.1558357173868838
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.011718684	1.1519783192994097
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.011718684	1.1519783192994097
COG8-CDG	0.011717749999999999	1.15188650457429
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.011717749999999999	1.15188650457429
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.011717749999999999	1.15188650457429
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.011717749999999999	1.15188650457429
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.011705214	1.1506541818825324
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.011705214	1.1506541818825324
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.011705214	1.1506541818825324
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.011705214	1.1506541818825324
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.01161212	1.1415027899978414
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.01135259	1.115990289344374
DILATED CARDIOMYOPATHY WITH ATAXIA	0.01115966	1.0970247487476283
KLEEFSTRA SYNDROME	0.010988664	1.0802153796506442
ISOLATED GLYCEROL KINASE DEFICIENCY	0.010962254000000001	1.0776192052497733
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.010962254000000001	1.0776192052497733
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.010962254000000001	1.0776192052497733
METHYLMALONIC ACIDURIA, CBLA TYPE	0.010962254000000001	1.0776192052497733
METHYLMALONIC ACIDURIA, CBLB TYPE	0.010962254000000001	1.0776192052497733
ISOVALERIC ACIDEMIA	0.010962254000000001	1.0776192052497733
MICROVILLUS INCLUSION DISEASE	0.010962254000000001	1.0776192052497733
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.010962254000000001	1.0776192052497733
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.010962254000000001	1.0776192052497733
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.010962254000000001	1.0776192052497733
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.010962254000000001	1.0776192052497733
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.010843154	1.065911353256447
NON-DISTAL MONOSOMY 10Q	0.01045594	1.0278471702023428
HEREDITARY FRUCTOSE INTOLERANCE	0.010416700000000001	1.0239897721148692
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.010416700000000001	1.0239897721148692
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.010416700000000001	1.0239897721148692
PRIMARY HYPEROXALURIA	0.010416700000000001	1.0239897721148692
HYPEROXALURIA, PRIMARY, TYPE I; HP1	0.010416700000000001	1.0239897721148692
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.010416700000000001	1.0239897721148692
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.010416700000000001	1.0239897721148692
MALIGNANT HYPERTHERMIA OF ANESTHESIA	0.010416700000000001	1.0239897721148692
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.010416700000000001	1.0239897721148692
GLUCOSE/GALACTOSE MALABSORPTION; GGM	0.010416700000000001	1.0239897721148692
SUDDEN CARDIAC FAILURE, INFANTILE	0.010416700000000001	1.0239897721148692
RIBOFLAVIN DEFICIENCY	0.010416700000000001	1.0239897721148692
LACTASE DEFICIENCY, CONGENITAL	0.010416700000000001	1.0239897721148692
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.010416700000000001	1.0239897721148692
NEUROLEPTIC MALIGNANT SYNDROME	0.010416700000000001	1.0239897721148692
HAWKINSINURIA	0.010416700000000001	1.0239897721148692
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.010416700000000001	1.0239897721148692
HAWKINSINURIA	0.010416700000000001	1.0239897721148692
GLUTARIC ACIDEMIA I; GA1	0.010416700000000001	1.0239897721148692
SMITH-MAGENIS SYNDROME	0.010126604	0.995472551024559
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.009935494	0.9766859213482819
MONOSOMY 5P	0.00979516	0.9628907097476822
HALL-RIGGS SYNDROME	0.00979516	0.9628907097476822
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.00979516	0.9628907097476822
TEMPLE-BARAITSER SYNDROME	0.00979516	0.9628907097476822
RING CHROMOSOME 7 SYNDROME	0.00979516	0.9628907097476822
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.00968668	0.9522268324661034
EPILEPSY-TELANGIECTASIA	0.00916422	0.9008676019670844
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.00903873	0.8885315956980456
14Q11.2 MICRODELETION SYNDROME	0.00903873	0.8885315956980456
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00903873	0.8885315956980456
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.00903873	0.8885315956980456
CRANIOFACIAL DYSSYNOSTOSIS	0.00903873	0.8885315956980456
ASPARTYLGLUCOSAMINURIA; AGU	0.00885465	0.870436034027756
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.00882462	0.867484003840018
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.00882462	0.867484003840018
ADENYLOSUCCINASE DEFICIENCY	0.008709394	0.8561569765202617
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.008709394	0.8561569765202617
PIERPONT SYNDROME	0.008709394	0.8561569765202617
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.008709394	0.8561569765202617
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.008643774	0.8497063531130234
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.008538144	0.8393226385365746
PELIZAEUS-MERZBACHER DISEASE	0.00851505	0.8370524359006898
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.00851505	0.8370524359006898
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.008344234	0.8202607612903456
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.008344234	0.8202607612903456
ISOLATED COMPLEX I DEFICIENCY	0.008344234	0.8202607612903456
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.008344233999999999	0.8202607612903454
INFANTILE LIVER FAILURE SYNDROME 1	0.008344233999999999	0.8202607612903454
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.008344233999999999	0.8202607612903454
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.008309644000000001	0.8168604707743998
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.008309644000000001	0.8168604707743998
BARATELA-SCOTT SYNDROME	0.008309644000000001	0.8168604707743998
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.008309644000000001	0.8168604707743998
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.008309644000000001	0.8168604707743998
FETAL TRIMETHADIONE SYNDROME	0.008309644000000001	0.8168604707743998
17Q21.31 MICRODUPLICATION SYNDROME	0.008309644000000001	0.8168604707743998
DESBUQUOIS DYSPLASIA 2; DBQD2	0.008309644000000001	0.8168604707743998
1Q44 MICRODELETION SYNDROME	0.008309644000000001	0.8168604707743998
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.008309644000000001	0.8168604707743998
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.008309644000000001	0.8168604707743998
MONOSOMY 9P	0.008309644000000001	0.8168604707743998
2Q31.1 MICRODELETION SYNDROME	0.008309644000000001	0.8168604707743998
19P13.12 MICRODELETION SYNDROME	0.008309644000000001	0.8168604707743998
HOLOPROSENCEPHALY	0.008309644	0.8168604707743996
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.008309644	0.8168604707743996
CHROMOSOME 1P36 DELETION SYNDROME	0.008309644	0.8168604707743996
HYPERMANGANESEMIA WITH DYSTONIA 2	0.008304174000000001	0.8163227549859573
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.008304174000000001	0.8163227549859573
NIEMANN-PICK DISEASE TYPE C	0.008304174000000001	0.8163227549859573
DISTAL MONOSOMY 10P	0.00816384	0.8025275433853575
SECKEL SYNDROME 7; SCKL7	0.00816384	0.8025275433853575
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00816384	0.8025275433853575
KEPPEN-LUBINSKY SYNDROME	0.00816384	0.8025275433853575
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.00816384	0.8025275433853575
ALLAN-HERNDON-DUDLEY SYNDROME	0.00816384	0.8025275433853575
YUNIS-VARON SYNDROME	0.00816384	0.8025275433853575
COFS SYNDROME	0.00816384	0.8025275433853575
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00816384	0.8025275433853575
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00816384	0.8025275433853575
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.00816384	0.8025275433853575
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.00816384	0.8025275433853575
MEHMO SYNDROME	0.00816384	0.8025275433853575
CROME SYNDROME	0.00816384	0.8025275433853575
21Q22.11Q22.12 MICRODELETION SYNDROME	0.00816384	0.8025275433853575
HENNEKAM-BEEMER SYNDROME	0.00816384	0.8025275433853575
ADENYLOSUCCINATE LYASE DEFICIENCY	0.00816384	0.8025275433853575
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.00816384	0.8025275433853575
LOWRY-MACLEAN SYNDROME	0.00816384	0.8025275433853575
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.00816384	0.8025275433853575
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00816384	0.8025275433853575
HEREDITARY METHEMOGLOBINEMIA	0.00816384	0.8025275433853575
DPM1-CDG	0.00816384	0.8025275433853575
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.00816384	0.8025275433853575
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.00816384	0.8025275433853575
BOWEN-CONRADI SYNDROME	0.00816384	0.8025275433853575
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.008151304	0.8012952206935998
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.008151304	0.8012952206935998
REFSUM DISEASE	0.00809822	0.7960769199781192
WEBB-DATTANI SYNDROME; WEDAS	0.007952964	0.7817978624706248
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.7817978624706248
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.007952964	0.7817978624706248
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.007952964	0.7817978624706248
300270 ADRENOMYODYSTROPHY	0.007952964	0.7817978624706248
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.007952964	0.7817978624706248
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.007952964	0.7817978624706248
3-HYDROXYISOBUTYRIC ACIDURIA	0.00779868	0.7666313281554414
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.00779868	0.7666313281554414
PSEUDO-TORCH SYNDROME 2	0.00779868	0.7666313281554414
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00779868	0.7666313281554414
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00779868	0.7666313281554414
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.00776409	0.7632310376394956
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.00776409	0.7632310376394956
MONOSOMY 22	0.00776409	0.7632310376394956
DUPLICATION/INVERSION 15Q11	0.00776409	0.7632310376394956
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00776409	0.7632310376394956
WIEDEMANN-STEINER SYNDROME	0.00776409	0.7632310376394956
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.00776409	0.7632310376394956
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.00776409	0.7632310376394956
ALEXANDER DISEASE	0.007758620000000001	0.7626933218510532
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.007758620000000001	0.7626933218510532
FAMILIAL COLORECTAL CANCER TYPE X	0.007758620000000001	0.7626933218510532
METACHROMATIC LEUKODYSTROPHY	0.007758620000000001	0.7626933218510532
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.007758620000000001	0.7626933218510532
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.007758620000000001	0.7626933218510532
LYNCH SYNDROME	0.007758620000000001	0.7626933218510532
CHOREOACANTHOCYTOSIS	0.007758620000000001	0.7626933218510532
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.007758620000000001	0.7626933218510532
CADASIL	0.007758620000000001	0.7626933218510532
ATAXIA WITH VITAMIN E DEFICIENCY	0.007758620000000001	0.7626933218510532
BEHÇET DISEASE	0.007758620000000001	0.7626933218510532
NEUROFERRITINOPATHY	0.007758620000000001	0.7626933218510532
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.007587804	0.7459016472407088
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.007587804	0.7459016472407088
NAVAJO NEUROHEPATOPATHY	0.007587804	0.7459016472407088
HYPOTONIA-CYSTINURIA SYNDROME	0.007587804	0.7459016472407088
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.007587804	0.7459016472407088
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.007587804	0.7459016472407088
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.007587804	0.7459016472407088
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.007587804	0.7459016472407088
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.007587804	0.7459016472407088
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.007587804	0.7459016472407088
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.007587804	0.7459016472407088
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.007587804	0.7459016472407088
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.007587804	0.7459016472407088
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.007587804	0.7459016472407088
2P21 MICRODELETION SYNDROME	0.007587804	0.7459016472407088
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.007587804	0.7459016472407088
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.007587804	0.7459016472407088
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.007587804	0.7459016472407088
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.007553214000000001	0.7425013567247631
WIEDEMANN-STEINER SYNDROME; WDSTS	0.007553214000000001	0.7425013567247631
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.007553214000000001	0.7425013567247631
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.007553214000000001	0.7425013567247631
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.007553214000000001	0.7425013567247631
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.007553214000000001	0.7425013567247631
2Q24 MICRODELETION SYNDROME	0.00740741	0.7281684293357208
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.00740741	0.7281684293357208
LISSENCEPHALY 5; LIS5	0.00740741	0.7281684293357208
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00740741	0.7281684293357208
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00740741	0.7281684293357208
GABRIELE-DE VRIES SYNDROME	0.00740741	0.7281684293357208
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.00740741	0.7281684293357208
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.00740741	0.7281684293357208
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.00740741	0.7281684293357208
FRYNS SYNDROME	0.00740741	0.7281684293357208
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.00740741	0.7281684293357208
ADRENOMYODYSTROPHY	0.00740741	0.7281684293357208
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.00740741	0.7281684293357208
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.7281684293357208
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.00740741	0.7281684293357208
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.00740741	0.7281684293357208
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00740741	0.7281684293357208
SMITH-FINEMAN-MYERS SYNDROME	0.00740741	0.7281684293357208
CONO-SPONDYLAR DYSPLASIA	0.00740741	0.7281684293357208
KID SYNDROME	0.00740741	0.7281684293357208
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.00740741	0.7281684293357208
ALLAN-HERNDON-DUDLEY SYNDROME	0.00740741	0.7281684293357208
PITT-HOPKINS-LIKE SYNDROME	0.00740741	0.7281684293357208
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.00740741	0.7281684293357208
1Q41Q42 MICRODELETION SYNDROME	0.00740741	0.7281684293357208
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.00740741	0.7281684293357208
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.00740741	0.7281684293357208
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00740741	0.7281684293357208
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.00740741	0.7281684293357208
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.00740741	0.7281684293357208
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.00740741	0.7281684293357208
WARBURG MICRO SYNDROME 2; WARBM2	0.00740741	0.7281684293357208
QAZI-MARKOUIZOS SYNDROME	0.00740741	0.7281684293357208
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.00740741	0.7281684293357208
GLUTAMINE DEFICIENCY, CONGENITAL	0.00740741	0.7281684293357208
TRISOMY 13	0.00740741	0.7281684293357208
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00740741	0.7281684293357208
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.00740741	0.7281684293357208
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.00740741	0.7281684293357208
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.00740741	0.7281684293357208
INTELLECTUAL DISABILITY, WOLFF TYPE	0.00740741	0.7281684293357208
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00740741	0.7281684293357208
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.007394874	0.7269361066439631
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.007394874	0.7269361066439631
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.007394874	0.7269361066439631
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.007394874	0.7269361066439631
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.007394874	0.7269361066439631
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.007394874	0.7269361066439631
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.007394874	0.7269361066439631
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.007394874	0.7269361066439631
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.007394874	0.7269361066439631
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.007394874	0.7269361066439631
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.007394874	0.7269361066439631
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.007394874	0.7269361066439631
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.007394874	0.7269361066439631
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.007394874	0.7269361066439631
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.007243644	0.7120697887854348
WITTEVEEN-KOLK SYNDROME	0.007243644	0.7120697887854348
RING CHROMOSOME 22 SYNDROME	0.007243644	0.7120697887854348
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00723616	0.711334091352034
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00723616	0.711334091352034
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00723616	0.711334091352034
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00723616	0.711334091352034
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.00704225	0.6922722141058049
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00704225	0.6922722141058049
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.00704225	0.6922722141058049
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.00704225	0.6922722141058049
MAPLE SYRUP URINE DISEASE; MSUD	0.00704225	0.6922722141058049
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.00704225	0.6922722141058049
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00704225	0.6922722141058049
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.00704225	0.6922722141058049
GLYCOGEN STORAGE DISEASE IXC	0.00704225	0.6922722141058049
PHENFORMIN 4-HYDROXYLATION	0.00704225	0.6922722141058049
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.00704225	0.6922722141058049
GRACILE SYNDROME	0.00704225	0.6922722141058049
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.00704225	0.6922722141058049
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.00704225	0.6922722141058049
SUCCINIC ACIDEMIA	0.00704225	0.6922722141058049
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.00704225	0.6922722141058049
MYOPATHY, MITOCHONDRIAL, LETHAL INFANTILE	0.00704225	0.6922722141058049
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.00704225	0.6922722141058049
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.00704225	0.6922722141058049
GLYCOGEN STORAGE DISEASE IB	0.00704225	0.6922722141058049
GLYCOGEN STORAGE DISEASE IA	0.00704225	0.6922722141058049
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.00704225	0.6922722141058049
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.00704225	0.6922722141058049
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.007007660000000001	0.688871923589859
LICHTENSTEIN SYNDROME	0.007007660000000001	0.688871923589859
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.007007660000000001	0.688871923589859
FOUNTAIN SYNDROME	0.007007660000000001	0.688871923589859
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.007007660000000001	0.688871923589859
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.007007660000000001	0.688871923589859
CEREBROFACIOTHORACIC DYSPLASIA	0.007007660000000001	0.688871923589859
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.007007660000000001	0.688871923589859
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.007007660000000001	0.688871923589859
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00684932	0.673306673509059
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.00684932	0.673306673509059
GLYCOGEN STORAGE DISEASE XI; GSD11	0.00684932	0.673306673509059
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00684932	0.673306673509059
GLYCOGEN STORAGE DISEASE 0, LIVER	0.00684932	0.673306673509059
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.00684932	0.673306673509059
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.00684932	0.673306673509059
GLYCOGEN STORAGE DISEASE DUE TO LACTATE DEHYDROGENASE DEFICIENCY	0.00684932	0.673306673509059
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.00684932	0.673306673509059
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00684932	0.673306673509059
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.00684932	0.673306673509059
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00684932	0.673306673509059
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.00684932	0.673306673509059
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.00684932	0.673306673509059
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.00684932	0.673306673509059
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00684932	0.673306673509059
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00684932	0.673306673509059
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00684932	0.673306673509059
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.00684932	0.673306673509059
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.00684932	0.673306673509059
LEBER OPTIC ATROPHY AND DYSTONIA	0.00684932	0.673306673509059
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00684932	0.673306673509059
AUTOSOMAL DOMINANT MITOCHONDRIAL MYOPATHY WITH EXERCISE INTOLERANCE	0.00684932	0.673306673509059
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.00684932	0.673306673509059
PERRAULT SYNDROME 5; PRLTS5	0.00684932	0.673306673509059
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00684932	0.673306673509059
BARAITSER-WINTER SYNDROME 1; BRWS1	0.006721183999999999	0.6607105582864153
CHROMOSOME 10Q26 DELETION SYNDROME	0.006721183999999999	0.6607105582864153
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.006721183999999999	0.6607105582864153
14Q12 MICRODELETION SYNDROME	0.006698089999999999	0.6584403556505307
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.006678324	0.656497304412075
HOLOPROSENCEPHALY 11	0.006678324	0.656497304412075
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.006678324	0.656497304412075
ALAZAMI-YUAN SYNDROME	0.006678324	0.656497304412075
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.006678324	0.656497304412075
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.006678324	0.656497304412075
KBG SYNDROME	0.006678324	0.656497304412075
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.006678324	0.656497304412075
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.006678324	0.656497304412075
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.006678324	0.656497304412075
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.006678324	0.656497304412075
GOLDBERG-SHPRINTZEN SYNDROME	0.006678324	0.656497304412075
BOHRING-OPITZ SYNDROME	0.006678324	0.656497304412075
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.006678324	0.656497304412075
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.006678324	0.656497304412075
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.006678324	0.656497304412075
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.006678324	0.656497304412075
HOLOPROSENCEPHALY 5; HPE5	0.006678324	0.656497304412075
12Q14 MICRODELETION SYNDROME	0.006678324	0.656497304412075
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.006487214	0.6377106747357981
2P15P16.1 MICRODELETION SYNDROME	0.006381583999999999	0.6273269601593493
PYRUVATE DEHYDROGENASE DEFICIENCY	0.006381583999999999	0.6273269601593493
1P36 DELETION SYNDROME	0.006381583999999999	0.6273269601593493
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00617563	0.6070811251515114
2Q23.1 MICRODELETION SYNDROME	0.00613277	0.6028678712771709
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00613277	0.6028678712771709
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.00613277	0.6028678712771709
CORNELIA DE LANGE SYNDROME 1	0.00613277	0.6028678712771709
BRANCHIOSKELETOGENITAL SYNDROME	0.00613277	0.6028678712771709
NON-DISTAL TRISOMY 13Q	0.00613277	0.6028678712771709
FONTAINE PROGEROID SYNDROME; FPS	0.00613277	0.6028678712771709
9Q SUBTELOMERIC DELETION SYNDROME	0.00613277	0.6028678712771709
CORNELIA DE LANGE SYNDROME	0.00613277	0.6028678712771709
20P13 MICRODELETION SYNDROME	0.00613277	0.6028678712771709
PIEBALDISM	0.00613277	0.6028678712771709
MICROTRIPLICATION 11Q24.1	0.00613277	0.6028678712771709
XYLT1-CDG	0.00613277	0.6028678712771709
KLEEFSTRA SYNDROME	0.00613277	0.6028678712771709
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.00613277	0.6028678712771709
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00613277	0.6028678712771709
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00613277	0.6028678712771709
CUTIS LAXA	0.005964753999999999	0.5863514442367788
CORNELIA DE LANGE SYNDROME 3	0.0059218940000000005	0.5821381903624383
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.0059218940000000005	0.5821381903624383
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.0059218940000000005	0.5821381903624383
DESANTO-SHINAWI SYNDROME	0.0059218940000000005	0.5821381903624383
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.0059218940000000005	0.5821381903624383
SMITH-MAGENIS SYNDROME; SMS	0.0059218940000000005	0.5821381903624383
ELSAHY-WATERS SYNDROME; ESWS	0.0059218940000000005	0.5821381903624383
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.0059218940000000005	0.5821381903624383
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.0059218940000000005	0.5821381903624383
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.0059218940000000005	0.5821381903624383
EVEN-PLUS SYNDROME	0.0059218940000000005	0.5821381903624383
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.0059218940000000005	0.5821381903624383
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.0059218940000000005	0.5821381903624383
GERMAN SYNDROME	0.0059218940000000005	0.5821381903624383
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.0059218940000000005	0.5821381903624383
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.0059218940000000005	0.5821381903624383
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.0059218940000000005	0.5821381903624383
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.0059218940000000005	0.5821381903624383
11P15.4 MICRODUPLICATION SYNDROME	0.0059218940000000005	0.5821381903624383
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.0059218940000000005	0.5821381903624383
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.005836030000000001	0.5736975270244453
TETRASOMY 18P	0.005836030000000001	0.5736975270244453
OROFACIODIGITAL SYNDROME TYPE 6	0.005625154	0.5529678461097127
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.005625154	0.5529678461097127
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.005625154	0.5529678461097127
COHEN-GIBSON SYNDROME; COGIS	0.005625154	0.5529678461097127
ALPERS-HUTTENLOCHER SYNDROME	0.005612324	0.5517066224231101
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.005612324	0.5517066224231101
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.005612324	0.5517066224231101
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.005612324	0.5517066224231101
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.005612324	0.5517066224231101
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.005612324	0.5517066224231101
AICARDI-GOUTIERES SYNDROME 7	0.005612324	0.5517066224231101
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.005612324	0.5517066224231101
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.005612324	0.5517066224231101
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.005612324	0.5517066224231101
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.005612324	0.5517066224231101
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.005612324	0.5517066224231101
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.005612324	0.5517066224231101
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.005612324	0.5517066224231101
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.005612324	0.5517066224231101
AICARDI-GOUTIÈRES SYNDROME	0.005612324	0.5517066224231101
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.005612324	0.5517066224231101
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.005612324	0.5517066224231101
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.005612324	0.5517066224231101
AICARDI-GOUTIERES SYNDROME 6	0.005612324	0.5517066224231101
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.005612324	0.5517066224231101
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.005612324	0.5517066224231101
MULTIPLE SULFATASE DEFICIENCY	0.005612324	0.5517066224231101
EHLERS-DANLOS SYNDROME, TYPE VI	0.0054192	0.5327220111018748
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.00537634	0.5285087572275342
WAARDENBURG-SHAH SYNDROME	0.00537634	0.5285087572275342
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.00537634	0.5285087572275342
WAARDENBURG SYNDROME TYPE 1	0.00537634	0.5285087572275342
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.00537634	0.5285087572275342
MCDONOUGH SYNDROME	0.00537634	0.5285087572275342
MCDONOUGH SYNDROME	0.00537634	0.5285087572275342
MENTAL RETARDATION, X-LINKED 73	0.00537634	0.5285087572275342
SOMATOMAMMOTROPINOMA	0.00537634	0.5285087572275342
17Q24.2 MICRODELETION SYNDROME	0.00537634	0.5285087572275342
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.00537634	0.5285087572275342
MARSHALL-SMITH SYNDROME; MRSHSS	0.00537634	0.5285087572275342
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.00537634	0.5285087572275342
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.00537634	0.5285087572275342
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.00537634	0.5285087572275342
17Q12 MICRODUPLICATION SYNDROME	0.00537634	0.5285087572275342
ZLOTOGORA-OGUR SYNDROME	0.00537634	0.5285087572275342
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.00537634	0.5285087572275342
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00537634	0.5285087572275342
ZIMMERMANN-LABAND SYNDROME 1	0.00537634	0.5285087572275342
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.00537634	0.5285087572275342
ACROMEGALY	0.00537634	0.5285087572275342
14Q24.1Q24.3 MICRODELETION SYNDROME	0.00537634	0.5285087572275342
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.00537634	0.5285087572275342
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.00537634	0.5285087572275342
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00537634	0.5285087572275342
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00537634	0.5285087572275342
MENTAL RETARDATION, X-LINKED 21	0.00537634	0.5285087572275342
GASTROCUTANEOUS SYNDROME	0.00537634	0.5285087572275342
TRANSALDOLASE DEFICIENCY	0.00537634	0.5285087572275342
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.00537634	0.5285087572275342
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00537634	0.5285087572275342
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.00537634	0.5285087572275342
WAARDENBURG SYNDROME	0.00537634	0.5285087572275342
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.00537634	0.5285087572275342
ACROOSTEOLYSIS DOMINANT TYPE	0.00537634	0.5285087572275342
PRIMROSE SYNDROME; PRIMS	0.00537634	0.5285087572275342
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.00537634	0.5285087572275342
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00537634	0.5285087572275342
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00537634	0.5285087572275342
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.00537634	0.5285087572275342
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.00537634	0.5285087572275342
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.00537634	0.5285087572275342
WAARDENBURG SYNDROME, TYPE 1; WS1	0.00537634	0.5285087572275342
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.00537634	0.5285087572275342
EDINBURGH MALFORMATION SYNDROME	0.00537634	0.5285087572275342
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00537634	0.5285087572275342
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.00537634	0.5285087572275342
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.00537634	0.5285087572275342
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.00537634	0.5285087572275342
ISOLATED TRIGONOCEPHALY	0.00537634	0.5285087572275342
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.00537634	0.5285087572275342
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.00537634	0.5285087572275342
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.005089864	0.5003473919240908
EMANUEL SYNDROME	0.0050898639999999995	0.5003473919240907
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.0050898639999999995	0.5003473919240907
MYOTONIA PERMANENS	0.0050796	0.49933841297480863
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.0050796	0.49933841297480863
MOEBIUS SYNDROME; MBS	0.0050796	0.49933841297480863
RETT SYNDROME	0.00506677	0.498077189288206
XERODERMA PIGMENTOSUM	0.00506677	0.498077189288206
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.00506677	0.498077189288206
MENKES DISEASE	0.00506677	0.498077189288206
TRIPLE A SYNDROME	0.00506677	0.498077189288206
NORRIE DISEASE	0.00506677	0.498077189288206
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.00506677	0.498077189288206
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.00506677	0.498077189288206
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	0.00506677	0.498077189288206
TAY-SACHS DISEASE	0.004855894	0.47734750837347345
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.004855894	0.47734750837347345
MYOCLONIC EPILEPSY OF INFANCY	0.004855894	0.47734750837347345
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.004855894	0.47734750837347345
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.004855894	0.47734750837347345
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.004855894	0.47734750837347345
ZTTK SYNDROME; ZTTKS	0.004855894	0.47734750837347345
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.004855894	0.47734750837347345
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.004855894	0.47734750837347345
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.004855894	0.47734750837347345
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.004855894	0.47734750837347345
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.004855894	0.47734750837347345
CHÉDIAK-HIGASHI SYNDROME	0.004855894	0.47734750837347345
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.004855894	0.47734750837347345
MUCOPOLYSACCHARIDOSIS TYPE 2	0.004855894	0.47734750837347345
SCHINDLER DISEASE, TYPE I	0.004855894	0.47734750837347345
CANAVAN DISEASE	0.004855894	0.47734750837347345
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.004855894	0.47734750837347345
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.004855894	0.47734750837347345
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.004855894	0.47734750837347345
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.004855894	0.47734750837347345
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.004855894	0.47734750837347345
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.004855894	0.47734750837347345
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.004855894	0.47734750837347345
MYOCLONIC-ASTASTIC EPILEPSY	0.004855894	0.47734750837347345
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.004855894	0.47734750837347345
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.004855894	0.47734750837347345
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.004855894	0.47734750837347345
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.004855894	0.47734750837347345
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.004855894	0.47734750837347345
OPTIC PATHWAY GLIOMA	0.004855894	0.47734750837347345
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.004855894	0.47734750837347345
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.004855894	0.47734750837347345
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.004855894	0.47734750837347345
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.004855894	0.47734750837347345
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.004855894	0.47734750837347345
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.004855894	0.47734750837347345
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.004855894	0.47734750837347345
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.004750264000000001	0.46696379379702474
RIDDLE SYNDROME	0.004750264000000001	0.46696379379702474
3Q29 MICRODELETION SYNDROME	0.004750264000000001	0.46696379379702474
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.004750264000000001	0.46696379379702474
16P13.2 MICRODELETION SYNDROME	0.004750264000000001	0.46696379379702474
46,XX GONADAL DYSGENESIS	0.00454431	0.4467179587891867
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00454431	0.4467179587891867
XYLOSIDASE DEFICIENCY	0.00454431	0.4467179587891867
CARDIAC LIPIDOSIS, FAMILIAL	0.00454431	0.4467179587891867
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00454431	0.4467179587891867
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00454431	0.4467179587891867
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.004333434	0.42598827787445404
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.004333434	0.42598827787445404
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.004333434	0.42598827787445404
LARSEN-LIKE SYNDROME	0.004333434	0.42598827787445404
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.004333434	0.42598827787445404
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.004333434	0.42598827787445404
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.004333434	0.42598827787445404
EPILEPSY, PYRIDOXINE-DEPENDENT	0.004333434	0.42598827787445404
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004333434	0.42598827787445404
REVESZ SYNDROME	0.004333434	0.42598827787445404
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.004333434	0.42598827787445404
SALLA DISEASE	0.004333434	0.42598827787445404
MUCOPOLYSACCHARIDOSIS TYPE 3	0.00431034	0.4237180752385693
GM2 GANGLIOSIDOSIS, AB VARIANT	0.00431034	0.4237180752385693
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.00431034	0.4237180752385693
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.00431034	0.4237180752385693
RETT SYNDROME; RTT	0.00431034	0.4237180752385693
PANDAS	0.00431034	0.4237180752385693
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.00431034	0.4237180752385693
CHILDHOOD DISINTEGRATIVE DISORDER	0.00431034	0.4237180752385693
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.00431034	0.4237180752385693
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00431034	0.4237180752385693
DYSOSTEOSCLEROSIS	0.00431034	0.4237180752385693
ADIPOSIS DOLOROSA	0.00431034	0.4237180752385693
CARNOSINASE DEFICIENCY	0.00431034	0.4237180752385693
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.00431034	0.4237180752385693
SPASTIC TETRAPLEGIA-RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY SYNDROME	0.00431034	0.4237180752385693
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.00431034	0.4237180752385693
TRISOMY 5P	0.00431034	0.4237180752385693
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.00431034	0.4237180752385693
WHIPPLE DISEASE	0.00431034	0.4237180752385693
CEREBROTENDINOUS XANTHOMATOSIS	0.00431034	0.4237180752385693
KRABBE DISEASE	0.00431034	0.4237180752385693
WOLFRAM SYNDROME	0.00431034	0.4237180752385693
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.00431034	0.4237180752385693
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.00431034	0.4237180752385693
SNEDDON SYNDROME	0.00431034	0.4237180752385693
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.00431034	0.4237180752385693
INFANTILE NEUROAXONAL DYSTROPHY	0.00431034	0.4237180752385693
ALEXANDER DISEASE	0.00431034	0.4237180752385693
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.00431034	0.4237180752385693
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.00431034	0.4237180752385693
CANAVAN DISEASE	0.00431034	0.4237180752385693
GAUCHER DISEASE	0.00431034	0.4237180752385693
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.00431034	0.4237180752385693
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00431034	0.4237180752385693
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.00431034	0.4237180752385693
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.00431034	0.4237180752385693
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.00431034	0.4237180752385693
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00431034	0.4237180752385693
WEST SYNDROME	0.00431034	0.4237180752385693
NASU-HAKOLA DISEASE	0.00431034	0.4237180752385693
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.00431034	0.4237180752385693
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.00431034	0.4237180752385693
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.00431034	0.4237180752385693
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.00431034	0.4237180752385693
RETT SYNDROME, CONGENITAL VARIANT	0.00431034	0.4237180752385693
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.00431034	0.4237180752385693
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00431034	0.4237180752385693
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00431034	0.4237180752385693
DYSOSTEOSCLEROSIS	0.00431034	0.4237180752385693
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00431034	0.4237180752385693
MUCOLIPIDOSIS TYPE IV	0.00420471	0.4133343606621206
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00420471	0.4133343606621206
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00420471	0.4133343606621206
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00420471	0.4133343606621206
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00420471	0.4133343606621206
SCHWARTZ-JAMPEL SYNDROME	0.00420471	0.4133343606621206
COCKAYNE SYNDROME A; CSA	0.00420471	0.4133343606621206
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.00420471	0.4133343606621206
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00420471	0.4133343606621206
JOUBERT SYNDROME	0.003993834	0.39260467974738794
JOUBERT SYNDROME WITH OCULAR DEFECT	0.003993834	0.39260467974738794
KRABBE DISEASE	0.003993834	0.39260467974738794
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.003993834	0.39260467974738794
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.003993834	0.39260467974738794
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.003993834	0.39260467974738794
FRIED SYNDROME	0.003993834	0.39260467974738794
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.003993834	0.39260467974738794
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.003993834	0.39260467974738794
HYDROCEPHALUS, NORMAL-PRESSURE	0.003993834	0.39260467974738794
INCONTINENTIA PIGMENTI	0.003993834	0.39260467974738794
FOIX-CHAVANY-MARIE SYNDROME	0.003993834	0.39260467974738794
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.003993834	0.39260467974738794
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.003993834	0.39260467974738794
JOUBERT SYNDROME 24	0.003993834	0.39260467974738794
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.003993834	0.39260467974738794
FREE SIALIC ACID STORAGE DISEASE	0.003993834	0.39260467974738794
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.003993834	0.39260467974738794
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.003993834	0.39260467974738794
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.003993834	0.39260467974738794
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.003993834	0.39260467974738794
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.003993834	0.39260467974738794
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.003993834	0.39260467974738794
SHWACHMAN-DIAMOND SYNDROME	0.003993834	0.39260467974738794
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.003993834	0.39260467974738794
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.003993834	0.39260467974738794
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.003993834	0.39260467974738794
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.003993834	0.39260467974738794
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.003993834	0.39260467974738794
JOUBERT SYNDROME WITH RENAL DEFECT	0.003993834	0.39260467974738794
L1 SYNDROME	0.003993834	0.39260467974738794
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00378788	0.37235884473955
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00378788	0.37235884473955
NEUTROPHIL ACTIN DYSFUNCTION	0.00378788	0.37235884473955
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00378788	0.37235884473955
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00378788	0.37235884473955
PERRY SYNDROME	0.00378788	0.37235884473955
SCHIZOPHRENIA 4	0.00378788	0.37235884473955
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00378788	0.37235884473955
257960 OCULOTRICHODYSPLASIA; OTD	0.00378788	0.37235884473955
OVARIAN CANCER	0.00378788	0.37235884473955
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00378788	0.37235884473955
ETHANOLAMINOSIS	0.00378788	0.37235884473955
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00378788	0.37235884473955
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00378788	0.37235884473955
PACMAN DYSPLASIA	0.00378788	0.37235884473955
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00378788	0.37235884473955
PARAOXONASE 1	0.00378788	0.37235884473955
GONADOBLASTOMA	0.00378788	0.37235884473955
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00378788	0.37235884473955
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.00378788	0.37235884473955
ONCOCYTOMA	0.00378788	0.37235884473955
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00378788	0.37235884473955
MACROCYTOSIS, FAMILIAL	0.00378788	0.37235884473955
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00378788	0.37235884473955
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00378788	0.37235884473955
OCULORENOCEREBELLAR SYNDROME	0.00378788	0.37235884473955
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00378788	0.37235884473955
NORMOKALEMIC PERIODIC PARALYSIS	0.00378788	0.37235884473955
OSTEOMESOPYKNOSIS	0.00378788	0.37235884473955
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00378788	0.37235884473955
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00378788	0.37235884473955
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.00378788	0.37235884473955
DELETED IN AZOOSPERMIA	0.00378788	0.37235884473955
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.00378788	0.37235884473955
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.00378788	0.37235884473955
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.00378788	0.37235884473955
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00378788	0.37235884473955
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00378788	0.37235884473955
XM SYSTEM	0.00378788	0.37235884473955
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00378788	0.37235884473955
MACULAR CORNEAL DYSTROPHY	0.00378788	0.37235884473955
CONE-ROD DYSTROPHY 1; CORD1	0.00378788	0.37235884473955
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00378788	0.37235884473955
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00378788	0.37235884473955
CITRULLINE TRANSPORT DEFECT	0.00378788	0.37235884473955
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00378788	0.37235884473955
PITUITARY DWARFISM IV	0.00378788	0.37235884473955
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00378788	0.37235884473955
XANTHINURIA, TYPE I	0.00378788	0.37235884473955
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00378788	0.37235884473955
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.00378788	0.37235884473955
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00378788	0.37235884473955
GLOMUVENOUS MALFORMATIONS	0.00378788	0.37235884473955
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00378788	0.37235884473955
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.00378788	0.37235884473955
GLUTATHIONE REDUCTASE	0.00378788	0.37235884473955
KERATOSIS, FAMILIAL ACTINIC	0.00378788	0.37235884473955
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00378788	0.37235884473955
PENDRED SYNDROME	0.00378788	0.37235884473955
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00378788	0.37235884473955
ACETYLATION, SLOW	0.00378788	0.37235884473955
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.00378788	0.37235884473955
ALKAPTONURIA	0.00378788	0.37235884473955
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00378788	0.37235884473955
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00378788	0.37235884473955
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00378788	0.37235884473955
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00378788	0.37235884473955
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00378788	0.37235884473955
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00378788	0.37235884473955
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00378788	0.37235884473955
HEINZ BODY ANEMIAS	0.00378788	0.37235884473955
HYPOASCORBEMIA	0.00378788	0.37235884473955
HYPERPROGLUCAGONEMIA	0.00378788	0.37235884473955
T-SUBSTANCE ANOMALY	0.00378788	0.37235884473955
DERMATITIS, ATOPIC	0.00378788	0.37235884473955
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.00378788	0.37235884473955
FLOOD FACTOR DEFICIENCY	0.00378788	0.37235884473955
APOLIPOPROTEIN(A)	0.00378788	0.37235884473955
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00378788	0.37235884473955
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00378788	0.37235884473955
HOOFT DISEASE	0.00378788	0.37235884473955
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00378788	0.37235884473955
TESTICULAR GERM CELL TUMOR; TGCT	0.00378788	0.37235884473955
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00378788	0.37235884473955
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00378788	0.37235884473955
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00378788	0.37235884473955
TRISOMY 18-LIKE SYNDROME	0.00378788	0.37235884473955
PROPERDIN DEFICIENCY, X-LINKED	0.00378788	0.37235884473955
MAGNESIUM, ELEVATED RED CELL	0.00378788	0.37235884473955
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00378788	0.37235884473955
CEREBELLOPARENCHYMAL DISORDER V	0.00378788	0.37235884473955
LYMPHOKINE DEFICIENCY	0.00378788	0.37235884473955
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00378788	0.37235884473955
OSTEOGENESIS IMPERFECTA, TYPE V	0.00378788	0.37235884473955
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00378788	0.37235884473955
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00378788	0.37235884473955
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00378788	0.37235884473955
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00378788	0.37235884473955
HYPERLEUCINE-ISOLEUCINEMIA	0.00378788	0.37235884473955
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00378788	0.37235884473955
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00378788	0.37235884473955
PROGESTERONE RESISTANCE	0.00378788	0.37235884473955
LIPASE DEFICIENCY, COMBINED	0.00378788	0.37235884473955
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00378788	0.37235884473955
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00378788	0.37235884473955
LARON SYNDROME	0.00378788	0.37235884473955
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00378788	0.37235884473955
ZINC, ELEVATED PLASMA	0.00378788	0.37235884473955
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00378788	0.37235884473955
COUMARIN RESISTANCE	0.00378788	0.37235884473955
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00378788	0.37235884473955
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00378788	0.37235884473955
SPERMATOGENIC FAILURE 1; SPGF1	0.00378788	0.37235884473955
GAPO SYNDROME; GAPOS	0.00378788	0.37235884473955
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00378788	0.37235884473955
PYGMY	0.00378788	0.37235884473955
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00378788	0.37235884473955
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00378788	0.37235884473955
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00378788	0.37235884473955
CALVARIAL HYPEROSTOSIS	0.00378788	0.37235884473955
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00378788	0.37235884473955
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00378788	0.37235884473955
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00378788	0.37235884473955
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.00378788	0.37235884473955
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00378788	0.37235884473955
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00378788	0.37235884473955
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00378788	0.37235884473955
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00378788	0.37235884473955
FINGERPRINT BODY MYOPATHY	0.00378788	0.37235884473955
%608572 BURN-MCKEOWN SYNDROME	0.00378788	0.37235884473955
CEPHALIN LIPIDOSIS	0.00378788	0.37235884473955
SERTOLI CELL-ONLY SYNDROME	0.00378788	0.37235884473955
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00378788	0.37235884473955
ALAND ISLAND EYE DISEASE	0.00378788	0.37235884473955
ICHTHYOSIS, X-LINKED	0.00378788	0.37235884473955
ICHTHYOSIS AND MALE HYPOGONADISM	0.00378788	0.37235884473955
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00378788	0.37235884473955
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00378788	0.37235884473955
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00378788	0.37235884473955
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00378788	0.37235884473955
PREMATURE CENTROMERE DIVISION; PCD	0.00378788	0.37235884473955
OSTEOGENIC SARCOMA	0.00378788	0.37235884473955
URATE-BINDING GLOBULIN, DECREASE IN	0.00378788	0.37235884473955
CONGENITAL ADRENAL HYPERPLASIA	0.00378788	0.37235884473955
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00378788	0.37235884473955
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00378788	0.37235884473955
FETAL IODINE DEFICIENCY DISORDER	0.00378788	0.37235884473955
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00378788	0.37235884473955
MYELOPEROXIDASE DEFICIENCY	0.00378788	0.37235884473955
MACULAR DYSTROPHY, CORNEAL, 1	0.00378788	0.37235884473955
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00378788	0.37235884473955
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00378788	0.37235884473955
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00378788	0.37235884473955
DERMATOLEUKODYSTROPHY	0.00378788	0.37235884473955
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00378788	0.37235884473955
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00378788	0.37235884473955
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00378788	0.37235884473955
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00378788	0.37235884473955
AREDYLD	0.00378788	0.37235884473955
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00378788	0.37235884473955
BEETURIA	0.00378788	0.37235884473955
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00378788	0.37235884473955
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00378788	0.37235884473955
BLOOD GROUP, DUFFY SYSTEM; FY	0.00378788	0.37235884473955
CARBOXYLESTERASE 1	0.00378788	0.37235884473955
GLUTATHIONURIA	0.00378788	0.37235884473955
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00378788	0.37235884473955
BARTTER SYNDROME	0.00378788	0.37235884473955
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00378788	0.37235884473955
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00378788	0.37235884473955
NEPHROSIALIDOSIS	0.00378788	0.37235884473955
POLYCYSTIC OVARY SYNDROME 1	0.00378788	0.37235884473955
PREMATURE OVARIAN FAILURE 1	0.00378788	0.37235884473955
MYOPATHY, SPHEROID BODY	0.00378788	0.37235884473955
CATECHOL-O-METHYLTRANSFERASE	0.00378788	0.37235884473955
WHITE SPONGE NEVUS OF CANNON	0.00378788	0.37235884473955
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00378788	0.37235884473955
LACTOSE INTOLERANCE, ADULT TYPE	0.00378788	0.37235884473955
SPINAL ARACHNOIDITIS	0.00378788	0.37235884473955
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00378788	0.37235884473955
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00378788	0.37235884473955
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00378788	0.37235884473955
LUTHERAN SUPPRESSOR, X-LINKED	0.00378788	0.37235884473955
CHOROIDAL OSTEOMA, BILATERAL	0.00378788	0.37235884473955
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00378788	0.37235884473955
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00378788	0.37235884473955
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00378788	0.37235884473955
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00378788	0.37235884473955
PALMOPLANTAR KERATODERMA-SPASTIC PARALYSIS SYNDROME	0.00344828	0.3389752466124839
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.00344828	0.3389752466124839
SPINOCEREBELLAR ATAXIA TYPE 17	0.00344828	0.3389752466124839
OSTEOGENESIS IMPERFECTA	0.00344828	0.3389752466124839
X-LINKED CENTRONUCLEAR MYOPATHY	0.00344828	0.3389752466124839
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00344828	0.3389752466124839
224550 DYSTONIA WITH RINGBINDEN	0.00344828	0.3389752466124839
MUSCLE-EYE-BRAIN DISEASE	0.00344828	0.3389752466124839
LAING EARLY-ONSET DISTAL MYOPATHY	0.00344828	0.3389752466124839
PELVIC DYSPLASIA-ARTHROGRYPOSIS OF LOWER LIMBS SYNDROME	0.00344828	0.3389752466124839
METACHROMATIC LEUKODYSTROPHY	0.00344828	0.3389752466124839
CENTRONUCLEAR MYOPATHY	0.00344828	0.3389752466124839
CLASSIC GALACTOSEMIA	0.00344828	0.3389752466124839
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00344828	0.3389752466124839
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.00344828	0.3389752466124839
BEHR SYNDROME	0.00344828	0.3389752466124839
SPONTANEOUS PERIODIC HYPOTHERMIA	0.00344828	0.3389752466124839
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.00344828	0.3389752466124839
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00344828	0.3389752466124839
HEREDITARY SPASTIC PARAPLEGIA	0.00344828	0.3389752466124839
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.00344828	0.3389752466124839
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.00344828	0.3389752466124839
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00344828	0.3389752466124839
MYOCLONIC EPILEPSY OF LAFORA	0.00344828	0.3389752466124839
SPASTIC PARAPLEGIA-FACIAL-CUTANEOUS LESIONS SYNDROME	0.00344828	0.3389752466124839
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2K	0.00344828	0.3389752466124839
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00344828	0.3389752466124839
DYSTONIA 16; DYT16	0.00344828	0.3389752466124839
SIALIDOSIS TYPE 1	0.00344828	0.3389752466124839
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.00344828	0.3389752466124839
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00344828	0.3389752466124839
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00344828	0.3389752466124839
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.00344828	0.3389752466124839
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.00344828	0.3389752466124839
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.00344828	0.3389752466124839
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.00344828	0.3389752466124839
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.00344828	0.3389752466124839
CORTICOBASAL SYNDROME	0.00344828	0.3389752466124839
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00344828	0.3389752466124839
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00344828	0.3389752466124839
HYPERKALEMIC PERIODIC PARALYSIS	0.00344828	0.3389752466124839
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.00344828	0.3389752466124839
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00344828	0.3389752466124839
BENIGN HEREDITARY CHOREA	0.00344828	0.3389752466124839
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.00344828	0.3389752466124839
ROUSSY-LÉVY SYNDROME	0.00344828	0.3389752466124839
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.00344828	0.3389752466124839
SPINOCEREBELLAR ATAXIA TYPE 4	0.00344828	0.3389752466124839
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.00344828	0.3389752466124839
RHEUMATIC FEVER	0.00344828	0.3389752466124839
ACETAZOLAMIDE-RESPONSIVE MYOTONIA	0.00344828	0.3389752466124839
MELNICK-NEEDLES SYNDROME	0.00344828	0.3389752466124839
MYOTONIA FLUCTUANS	0.00344828	0.3389752466124839
NEUROFIBROMATOSIS TYPE 2	0.00344828	0.3389752466124839
MANGANESE POISONING	0.00344828	0.3389752466124839
HEREDITARY HYPEREKPLEXIA	0.00344828	0.3389752466124839
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.00344828	0.3389752466124839
ADULT POLYGLUCOSAN BODY DISEASE	0.00344828	0.3389752466124839
MAST SYNDROME	0.00344828	0.3389752466124839
PSEUDOACHONDROPLASIA	0.00344828	0.3389752466124839
THORACOMELIC DYSPLASIA	0.00344828	0.3389752466124839
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.00344828	0.3389752466124839
KUSKOKWIM SYNDROME	0.00344828	0.3389752466124839
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.00344828	0.3389752466124839
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00344828	0.3389752466124839
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00344828	0.3389752466124839
LERI PLEONOSTEOSIS	0.00344828	0.3389752466124839
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.00344828	0.3389752466124839
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00344828	0.3389752466124839
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00344828	0.3389752466124839
ATAXIA-OCULOMOTOR APRAXIA TYPE 1	0.00344828	0.3389752466124839
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.00344828	0.3389752466124839
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00344828	0.3389752466124839
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.00344828	0.3389752466124839
POLYMYOSITIS	0.00344828	0.3389752466124839
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00344828	0.3389752466124839
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00344828	0.3389752466124839
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.00344828	0.3389752466124839
ATAXIA-TELANGIECTASIA	0.00344828	0.3389752466124839
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.00344828	0.3389752466124839
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.00344828	0.3389752466124839
RICHARDS-RUNDLE SYNDROME	0.00344828	0.3389752466124839
CYSTINOSIS	0.00344828	0.3389752466124839
MUTILATING HEREDITARY SENSORY NEUROPATHY WITH SPASTIC PARAPLEGIA	0.00344828	0.3389752466124839
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.00344828	0.3389752466124839
PRIMARY DYSTONIA, DYT4 TYPE	0.00344828	0.3389752466124839
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00344828	0.3389752466124839
POTASSIUM-AGGRAVATED MYOTONIA	0.00344828	0.3389752466124839
FAMILIAL DYSAUTONOMIA	0.00344828	0.3389752466124839
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.00344828	0.3389752466124839
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00344828	0.3389752466124839
DYSEQUILIBRIUM SYNDROME	0.00344828	0.3389752466124839
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.00344828	0.3389752466124839
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00344828	0.3389752466124839
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.00344828	0.3389752466124839
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.00344828	0.3389752466124839
GAUCHER DISEASE TYPE 3	0.00344828	0.3389752466124839
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00344828	0.3389752466124839
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.00344828	0.3389752466124839
MYOPATHY, DISTAL, 1; MPD1	0.00344828	0.3389752466124839
LATE-ONSET DISTAL MYOPATHY, MARKESBERY-GRIGGS TYPE	0.00344828	0.3389752466124839
PSYCHOGENIC MOVEMENT DISORDERS	0.00344828	0.3389752466124839
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00344828	0.3389752466124839
DOPA-RESPONSIVE DYSTONIA	0.00344828	0.3389752466124839
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00344828	0.3389752466124839
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00344828	0.3389752466124839
NEMALINE MYOPATHY 7; NEM7	0.00344828	0.3389752466124839
KALLMANN SYNDROME	0.00344828	0.3389752466124839
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00344828	0.3389752466124839
SPONDYLOMETAPHYSEAL DYSPLASIA	0.00344828	0.3389752466124839
TENORIO SYNDROME; TNORS	0.00344828	0.3389752466124839
TRYPTOPHANURIA WITH DWARFISM	0.00344828	0.3389752466124839
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00344828	0.3389752466124839
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00344828	0.3389752466124839
BRITTLE CORNEA SYNDROME 2; BCS2	0.00344828	0.3389752466124839
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.00344828	0.3389752466124839
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.00344828	0.3389752466124839
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00344828	0.3389752466124839
AMYOTROPHIC LATERAL SCLEROSIS TYPE 4	0.00344828	0.3389752466124839
NEMALINE MYOPATHY 6	0.00344828	0.3389752466124839
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.00344828	0.3389752466124839
MASA SYNDROME	0.00344828	0.3389752466124839
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.00344828	0.3389752466124839
BRITTLE CORNEA SYNDROME	0.00344828	0.3389752466124839
SPONASTRIME DYSPLASIA	0.00344828	0.3389752466124839
EARLY-ONSET GENERALIZED LIMB-ONSET DYSTONIA	0.00344828	0.3389752466124839
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.00344828	0.3389752466124839
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.00344828	0.3389752466124839
CHOREOATHETOSIS, FAMILIAL INVERTED	0.00344828	0.3389752466124839
IDIOPATHIC JUVENILE OSTEOPOROSIS	0.00344828	0.3389752466124839
MULTIPLE METAPHYSEAL DYSPLASIA	0.00344828	0.3389752466124839
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.00344828	0.3389752466124839
KUFOR-RAKEB SYNDROME	0.00344828	0.3389752466124839
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.00344828	0.3389752466124839
MULTIPLE SYMMETRIC LIPOMATOSIS	0.00344828	0.3389752466124839
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.00344828	0.3389752466124839
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00344828	0.3389752466124839
PARTINGTON SYNDROME	0.00344828	0.3389752466124839
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00344828	0.3389752466124839
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 5	0.00344828	0.3389752466124839
DYSTONIA 23; DYT23	0.00344828	0.3389752466124839
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 1	0.00344828	0.3389752466124839
OSTEOCHONDRITIS DISSECANS	0.00344828	0.3389752466124839
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.00344828	0.3389752466124839
AUTOSOMAL DOMINANT STRIATAL NEURODEGENERATION	0.00344828	0.3389752466124839
SUBEPENDYMOMA	0.00344828	0.3389752466124839
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.00344828	0.3389752466124839
GLYCOGEN STORAGE DISEASE DUE TO LAMP-2 DEFICIENCY	0.00344828	0.3389752466124839
EPENDYMOMA	0.00344828	0.3389752466124839
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.00344828	0.3389752466124839
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.00344828	0.3389752466124839
KENNEDY DISEASE	0.00344828	0.3389752466124839
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00344828	0.3389752466124839
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00344828	0.3389752466124839
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.00344828	0.3389752466124839
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00344828	0.3389752466124839
NONAKA MYOPATHY	0.00344828	0.3389752466124839
ALZHEIMER DISEASE 3; AD	0.00344828	0.3389752466124839
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.0029333040000000003	0.2883517135468655
DISTAL MONOSOMY 1Q	0.0029333040000000003	0.2883517135468655
RING CHROMOSOME 14 SYNDROME	0.0029333040000000003	0.2883517135468655
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.0029333040000000003	0.2883517135468655
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.0029333040000000003	0.2883517135468655
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.0029333040000000003	0.2883517135468655
PHENOBARBITAL EMBRYOPATHY	0.0029333040000000003	0.2883517135468655
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.0029333040000000003	0.2883517135468655
HARTSFIELD SYNDROME; HRTFDS	0.0029333039999999994	0.28835171354686545
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.0029333039999999994	0.28835171354686545
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.0029333039999999994	0.28835171354686545
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.0029333039999999994	0.28835171354686545
COFFIN-SIRIS SYNDROME	0.0029333039999999994	0.28835171354686545
SMITH-LEMLI-OPITZ SYNDROME	0.0029333039999999994	0.28835171354686545
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.0029333039999999994	0.28835171354686545
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.0029333039999999994	0.28835171354686545
CK SYNDROME	0.0029333039999999994	0.28835171354686545
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.0029333039999999994	0.28835171354686545
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.0029333039999999994	0.28835171354686545
10Q22.3Q23.3 MICRODELETION SYNDROME	0.0029333039999999994	0.28835171354686545
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.0029333039999999994	0.28835171354686545
OGDEN SYNDROME; OGDNS	0.0029333039999999994	0.28835171354686545
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.0029333039999999994	0.28835171354686545
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.0029333039999999994	0.28835171354686545
TOLUENE EMBRYOPATHY	0.0029333039999999994	0.28835171354686545
TRICHOTHIODYSTROPHY	0.0029333039999999994	0.28835171354686545
MONOSOMY 13Q34	0.0029333039999999994	0.28835171354686545
LATHOSTEROLOSIS	0.0029333039999999994	0.28835171354686545
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.0029333039999999994	0.28835171354686545
HOLMES-GANG SYNDROME	0.0029333039999999994	0.28835171354686545
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.0029333039999999994	0.28835171354686545
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.0029333039999999994	0.28835171354686545
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.0029333039999999994	0.28835171354686545
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0029333039999999994	0.28835171354686545
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.0029333039999999994	0.28835171354686545
ROTHMUND-THOMSON SYNDROME	0.0029333039999999994	0.28835171354686545
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.0029333039999999994	0.28835171354686545
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.0029333039999999994	0.28835171354686545
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.0029333039999999994	0.28835171354686545
1Q21.1 MICRODELETION SYNDROME	0.0029333039999999994	0.28835171354686545
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0029333039999999994	0.28835171354686545
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.0029333039999999994	0.28835171354686545
FANCONI ANEMIA	0.0029333039999999994	0.28835171354686545
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.0029333039999999994	0.28835171354686545
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.0029333039999999994	0.28835171354686545
22Q11.2 DELETION SYNDROME	0.0029333039999999994	0.28835171354686545
LIG4 SYNDROME	0.0029333039999999994	0.28835171354686545
DISTAL MONOSOMY 10Q	0.0029333039999999994	0.28835171354686545
CHARGE SYNDROME	0.0029333039999999994	0.28835171354686545
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.0029333039999999994	0.28835171354686545
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.0029333039999999994	0.28835171354686545
6Q16 MICRODELETION SYNDROME	0.0029333039999999994	0.28835171354686545
C SYNDROME	0.0029333039999999994	0.28835171354686545
15Q24 MICRODELETION SYNDROME	0.0029333039999999994	0.28835171354686545
RUBINSTEIN-TAYBI SYNDROME	0.0029333039999999994	0.28835171354686545
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.0029333039999999994	0.28835171354686545
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.0029333039999999994	0.28835171354686545
DISTAL TRISOMY 17Q	0.0029333039999999994	0.28835171354686545
MONOSOMY 18P	0.0029333039999999994	0.28835171354686545
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.0029333039999999994	0.28835171354686545
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.0029333039999999994	0.28835171354686545
WARSAW BREAKAGE SYNDROME; WABS	0.0029333039999999994	0.28835171354686545
8P23.1 MICRODELETION SYNDROME	0.0029333039999999994	0.28835171354686545
MONOSOMY 18Q	0.0029333039999999994	0.28835171354686545
22Q11.2 MICRODUPLICATION SYNDROME	0.0029333039999999994	0.28835171354686545
19P13.3 MICRODUPLICATION SYNDROME	0.0029333039999999994	0.28835171354686545
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.0029333039999999994	0.28835171354686545
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.0029333039999999994	0.28835171354686545
MATERNAL PHENYLKETONURIA	0.0029333039999999994	0.28835171354686545
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.0029333039999999994	0.28835171354686545
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.0029333039999999994	0.28835171354686545
20Q11.2 MICRODUPLICATION SYNDROME	0.0029333039999999994	0.28835171354686545
8P11.2 DELETION SYNDROME	0.0029333039999999994	0.28835171354686545
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.0029333039999999994	0.28835171354686545
6Q25 MICRODELETION SYNDROME	0.0029333039999999994	0.28835171354686545
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0029333039999999994	0.28835171354686545
PEHO SYNDROME	0.0029333039999999994	0.28835171354686545
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.0029333039999999994	0.28835171354686545
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.0029333039999999994	0.28835171354686545
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.0029333039999999994	0.28835171354686545
HADZISELIMOVIC SYNDROME	0.0029333039999999994	0.28835171354686545
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.0029333039999999994	0.28835171354686545
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.0029333039999999994	0.28835171354686545
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.0029333039999999994	0.28835171354686545
FETAL ALCOHOL SYNDROME	0.0029333039999999994	0.28835171354686545
KOOLEN-DE VRIES SYNDROME	0.0029333039999999994	0.28835171354686545
15Q13.3 MICRODELETION SYNDROME	0.0029333039999999994	0.28835171354686545
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.0029333039999999994	0.28835171354686545
CEREBROFACIOARTICULAR SYNDROME	0.0029333039999999994	0.28835171354686545
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.0029333039999999994	0.28835171354686545
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.0029333039999999994	0.28835171354686545
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.0029333039999999994	0.28835171354686545
MARDEN-WALKER SYNDROME	0.00238775	0.23472228041196147
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00238775	0.23472228041196147
DUBOWITZ SYNDROME	0.00238775	0.23472228041196147
OCULODENTODIGITAL DYSPLASIA; ODDD	0.00238775	0.23472228041196147
RING CHROMOSOME 13 SYNDROME	0.00238775	0.23472228041196147
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00238775	0.23472228041196147
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00238775	0.23472228041196147
RENPENNING SYNDROME 1; RENS1	0.00238775	0.23472228041196147
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00238775	0.23472228041196147
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00238775	0.23472228041196147
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.00238775	0.23472228041196147
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.00238775	0.23472228041196147
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00238775	0.23472228041196147
ACHALASIA-MICROCEPHALY SYNDROME	0.00238775	0.23472228041196147
LATHOSTEROLOSIS	0.00238775	0.23472228041196147
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.00238775	0.23472228041196147
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.00238775	0.23472228041196147
C SYNDROME	0.00238775	0.23472228041196147
COFFIN-SIRIS SYNDROME 10; CSS10	0.00238775	0.23472228041196147
MARTSOLF SYNDROME	0.00238775	0.23472228041196147
CAREY-FINEMAN-ZITER SYNDROME	0.00238775	0.23472228041196147
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.00238775	0.23472228041196147
DESMOSTEROLOSIS	0.00238775	0.23472228041196147
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00238775	0.23472228041196147
OROFACIODIGITAL SYNDROME I; OFD1	0.00238775	0.23472228041196147
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.00238775	0.23472228041196147
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.00238775	0.23472228041196147
FEINGOLD SYNDROME 1; FGLDS1	0.00238775	0.23472228041196147
CRI-DU-CHAT SYNDROME	0.00238775	0.23472228041196147
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.00238775	0.23472228041196147
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00238775	0.23472228041196147
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00238775	0.23472228041196147
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00238775	0.23472228041196147
DUBOWITZ SYNDROME	0.00238775	0.23472228041196147
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00238775	0.23472228041196147
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.00238775	0.23472228041196147
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00238775	0.23472228041196147
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00238775	0.23472228041196147
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00238775	0.23472228041196147
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00238775	0.23472228041196147
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00238775	0.23472228041196147
CHROMOSOME 18Q DELETION SYNDROME	0.00238775	0.23472228041196147
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00238775	0.23472228041196147
JACOBSEN SYNDROME	0.00238775	0.23472228041196147
RENPENNING SYNDROME	0.00238775	0.23472228041196147
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.00238775	0.23472228041196147
DISTAL MONOSOMY 3P	0.00238775	0.23472228041196147
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.00238775	0.23472228041196147
MOWAT-WILSON SYNDROME	0.00238775	0.23472228041196147
MONOSOMY 13Q14	0.00238775	0.23472228041196147
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00238775	0.23472228041196147
ACROOTOOCULAR SYNDROME	0.00238775	0.23472228041196147
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00238775	0.23472228041196147
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00238775	0.23472228041196147
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00238775	0.23472228041196147
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.00238775	0.23472228041196147
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00238775	0.23472228041196147
PRIMARY PULMONARY HYPOPLASIA	0.00238775	0.23472228041196147
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.00238775	0.23472228041196147
RING CHROMOSOME 6 SYNDROME	0.00238775	0.23472228041196147
DISTAL TRISOMY 5Q	0.00238775	0.23472228041196147
DIAMOND-BLACKFAN ANEMIA 1	0.00238775	0.23472228041196147
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00238775	0.23472228041196147
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.00238775	0.23472228041196147
GMS SYNDROME	0.00238775	0.23472228041196147
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.0021768739999999996	0.21399259949722882
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.0021768739999999996	0.21399259949722882
PSEUDOAMINOPTERIN SYNDROME	0.0021768739999999996	0.21399259949722882
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.0021768739999999996	0.21399259949722882
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.0021768739999999996	0.21399259949722882
NOONAN SYNDROME 3; NS3	0.0021768739999999996	0.21399259949722882
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.0021768739999999996	0.21399259949722882
CHROMOSOME 16Q22 DELETION SYNDROME	0.0021768739999999996	0.21399259949722882
NOONAN SYNDROME 6; NS6	0.0021768739999999996	0.21399259949722882
JACOBSEN SYNDROME	0.0021768739999999996	0.21399259949722882
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.0021768739999999996	0.21399259949722882
LYMPHEDEMA, HEREDITARY, III	0.0021768739999999996	0.21399259949722882
16P11.2P12.2 MICRODELETION SYNDROME	0.0021768739999999996	0.21399259949722882
20P12.3 MICRODELETION SYNDROME	0.0021768739999999996	0.21399259949722882
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.0021768739999999996	0.21399259949722882
ICF SYNDROME	0.0021768739999999996	0.21399259949722882
48,XYYY SYNDROME	0.0021768739999999996	0.21399259949722882
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.0021768739999999996	0.21399259949722882
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.0021768739999999996	0.21399259949722882
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.0021768739999999996	0.21399259949722882
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.0021768739999999996	0.21399259949722882
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.0021768739999999996	0.21399259949722882
PMM2-CDG	0.0021768739999999996	0.21399259949722882
PEHO SYNDROME; PEHO	0.0021768739999999996	0.21399259949722882
TETRASOMY X	0.0021768739999999996	0.21399259949722882
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.0021768739999999996	0.21399259949722882
X SMALL RINGS	0.0021768739999999996	0.21399259949722882
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.0021768739999999996	0.21399259949722882
WEAVER SYNDROME	0.0021768739999999996	0.21399259949722882
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.0021768739999999996	0.21399259949722882
TRISOMY X	0.0021768739999999996	0.21399259949722882
SIMPSON-GOLABI-BEHMEL SYNDROME	0.0021768739999999996	0.21399259949722882
TRISOMY 12P	0.0021768739999999996	0.21399259949722882
INFANTILE SIALIC ACID STORAGE DISEASE	0.0021768739999999996	0.21399259949722882
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.0021768739999999996	0.21399259949722882
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.0021768739999999996	0.21399259949722882
8Q12 MICRODUPLICATION SYNDROME	0.0021768739999999996	0.21399259949722882
DISTAL MONOSOMY 9P	0.0021768739999999996	0.21399259949722882
14Q22Q23 MICRODELETION SYNDROME	0.0021768739999999996	0.21399259949722882
DIAPHANOSPONDYLODYSOSTOSIS	0.0021768739999999996	0.21399259949722882
OPITZ G/BBB SYNDROME	0.0021768739999999996	0.21399259949722882
8Q24.3 MICRODELETION SYNDROME	0.0021768739999999996	0.21399259949722882
48,XXYY SYNDROME	0.0021768739999999996	0.21399259949722882
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.0021768739999999996	0.21399259949722882
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.0021768739999999996	0.21399259949722882
COSTELLO SYNDROME; CSTLO	0.0021768739999999996	0.21399259949722882
TETRASOMY 9P	0.0021768739999999996	0.21399259949722882
DISTAL MONOSOMY 6P	0.0021768739999999996	0.21399259949722882
DE BARSY SYNDROME	0.0021768739999999996	0.21399259949722882
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.0021768739999999996	0.21399259949722882
TETRASOMY 5P	0.0021768739999999996	0.21399259949722882
OROFACIODIGITAL SYNDROME VI	0.0021768739999999996	0.21399259949722882
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.0021768739999999996	0.21399259949722882
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.0021768739999999996	0.21399259949722882
MENTAL RETARDATION, X-LINKED 91; MRX91	0.0021768739999999996	0.21399259949722882
TEMPLE-BARAITSER SYNDROME; TMBTS	0.0021768739999999996	0.21399259949722882
19P13.13 MICRODELETION SYNDROME	0.0021768739999999996	0.21399259949722882
THAUVIN-ROBINET-FAIVRE SYNDROME	0.0021768739999999996	0.21399259949722882
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.0021768739999999996	0.21399259949722882
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.0021768739999999996	0.21399259949722882
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.0021768739999999996	0.21399259949722882
NOONAN SYNDROME 5; NS5	0.0021768739999999996	0.21399259949722882
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.0021768739999999996	0.21399259949722882
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.0021768739999999996	0.21399259949722882
WRINKLY SKIN SYNDROME	0.0021768739999999996	0.21399259949722882
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.0021768739999999996	0.21399259949722882
11Q22.2Q22.3 MICRODELETION SYNDROME	0.0021768739999999996	0.21399259949722882
PEHO-LIKE SYNDROME; PEHOL	0.0021768739999999996	0.21399259949722882
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.0021768739999999996	0.21399259949722882
AARSKOG-SCOTT SYNDROME	0.0021768739999999996	0.21399259949722882
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0021768739999999996	0.21399259949722882
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.0021768739999999996	0.21399259949722882
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0021768739999999996	0.21399259949722882
15Q11Q13 MICRODUPLICATION SYNDROME	0.0021768739999999996	0.21399259949722882
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.0021768739999999996	0.21399259949722882
JOUBERT SYNDROME 14	0.0021768739999999996	0.21399259949722882
PERLMAN SYNDROME	0.0021768739999999996	0.21399259949722882
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.0021768739999999996	0.21399259949722882
POTOCKI-SHAFFER SYNDROME	0.0021768739999999996	0.21399259949722882
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.0021768739999999996	0.21399259949722882
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.0021768739999999996	0.21399259949722882
SIALURIA	0.0021768739999999996	0.21399259949722882
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.0021768739999999996	0.21399259949722882
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.0021768739999999996	0.21399259949722882
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.0021768739999999996	0.21399259949722882
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.0021768739999999996	0.21399259949722882
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.0021768739999999996	0.21399259949722882
JOUBERT SYNDROME 10	0.0021768739999999996	0.21399259949722882
CODAS SYNDROME	0.0021768739999999996	0.21399259949722882
CARDIOFACIOCUTANEOUS SYNDROME	0.0021768739999999996	0.21399259949722882
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.0021768739999999996	0.21399259949722882
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.0021768739999999996	0.21399259949722882
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.0021768739999999996	0.21399259949722882
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.0021768739999999996	0.21399259949722882
MONOSOMY 9Q22.3	0.0021768739999999996	0.21399259949722882
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.0021768739999999996	0.21399259949722882
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.0021768739999999996	0.21399259949722882
48,XXXY SYNDROME	0.0021768739999999996	0.21399259949722882
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.0021768739999999996	0.21399259949722882
COFFIN-SIRIS SYNDROME 6; CSS6	0.0021768739999999996	0.21399259949722882
49,XXXXY SYNDROME	0.0021768739999999996	0.21399259949722882
XQ25 MICRODUPLICATION SYNDROME	0.0021768739999999996	0.21399259949722882
MONOSOMY 22Q13.3	0.0021768739999999996	0.21399259949722882
LATERAL MENINGOCELE SYNDROME	0.0021768739999999996	0.21399259949722882
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.0021768739999999996	0.21399259949722882
FRONTOOCULAR SYNDROME	0.0021768739999999996	0.21399259949722882
XQ25 DUPLICATION SYNDROME	0.0021768739999999996	0.21399259949722882
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.0021768739999999996	0.21399259949722882
JOUBERT SYNDROME 1	0.0021768739999999996	0.21399259949722882
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.0021768739999999996	0.21399259949722882
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.0021768739999999996	0.21399259949722882
BAKER-GORDON SYNDROME; BAGOS	0.0021768739999999996	0.21399259949722882
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.0021768739999999996	0.21399259949722882
CHROMOSOME 9P DELETION SYNDROME	0.0021768739999999996	0.21399259949722882
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.0021768739999999996	0.21399259949722882
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.0021768739999999996	0.21399259949722882
LAMB-SHAFFER SYNDROME	0.0021768739999999996	0.21399259949722882
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00163132	0.16036316636232473
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00163132	0.16036316636232473
CARTILAGE-HAIR HYPOPLASIA	0.00163132	0.16036316636232473
ACRODYSOSTOSIS	0.00163132	0.16036316636232473
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.00163132	0.16036316636232473
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00163132	0.16036316636232473
RING CHROMOSOME 8 SYNDROME	0.00163132	0.16036316636232473
NOONAN SYNDROME 8; NS8	0.00163132	0.16036316636232473
OROFACIODIGITAL SYNDROME TYPE 1	0.00163132	0.16036316636232473
ACRO-RENAL-OCULAR SYNDROME	0.00163132	0.16036316636232473
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00163132	0.16036316636232473
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00163132	0.16036316636232473
RENAL AGENESIS, BILATERAL	0.00163132	0.16036316636232473
MOMO SYNDROME	0.00163132	0.16036316636232473
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.00163132	0.16036316636232473
MOEBIUS SYNDROME	0.00163132	0.16036316636232473
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.00163132	0.16036316636232473
JUBERG-MARSIDI SYNDROME	0.00163132	0.16036316636232473
ATELOSTEOGENESIS TYPE II	0.00163132	0.16036316636232473
CRANIOECTODERMAL DYSPLASIA	0.00163132	0.16036316636232473
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00163132	0.16036316636232473
HYPOGLOSSIA-HYPODACTYLIA	0.00163132	0.16036316636232473
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00163132	0.16036316636232473
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00163132	0.16036316636232473
SCHOLTE SYNDROME; SHLTS	0.00163132	0.16036316636232473
KNOBLOCH SYNDROME	0.00163132	0.16036316636232473
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00163132	0.16036316636232473
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00163132	0.16036316636232473
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00163132	0.16036316636232473
BALLER-GEROLD SYNDROME	0.00163132	0.16036316636232473
OMODYSPLASIA 1; OMOD1	0.00163132	0.16036316636232473
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00163132	0.16036316636232473
6P22 MICRODELETION SYNDROME	0.00163132	0.16036316636232473
OROFACIODIGITAL SYNDROME IV; OFD4	0.00163132	0.16036316636232473
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.00163132	0.16036316636232473
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00163132	0.16036316636232473
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.00163132	0.16036316636232473
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.00163132	0.16036316636232473
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00163132	0.16036316636232473
BRITTLE CORNEA SYNDROME	0.00163132	0.16036316636232473
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00163132	0.16036316636232473
JOUBERT SYNDROME 3; JBTS3	0.00163132	0.16036316636232473
HYPOTONIA-CYSTINURIA SYNDROME	0.00163132	0.16036316636232473
3Q13 MICRODELETION SYNDROME	0.00163132	0.16036316636232473
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.00163132	0.16036316636232473
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00163132	0.16036316636232473
NEUROFACIODIGITORENAL SYNDROME	0.00163132	0.16036316636232473
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.00163132	0.16036316636232473
PROGEROID SYNDROME, PETTY TYPE	0.00163132	0.16036316636232473
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.00163132	0.16036316636232473
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.00163132	0.16036316636232473
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00163132	0.16036316636232473
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00163132	0.16036316636232473
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.00163132	0.16036316636232473
FRONTONASAL DYSPLASIA 1; FND1	0.00163132	0.16036316636232473
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.00163132	0.16036316636232473
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.00163132	0.16036316636232473
HENNEKAM SYNDROME	0.00163132	0.16036316636232473
ZUNICH NEUROECTODERMAL SYNDROME	0.00163132	0.16036316636232473
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.00163132	0.16036316636232473
3P25.3 MICRODELETION SYNDROME	0.00163132	0.16036316636232473
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.00163132	0.16036316636232473
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.00163132	0.16036316636232473
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00163132	0.16036316636232473
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.00163132	0.16036316636232473
CRANIOECTODERMAL DYSPLASIA 1	0.00163132	0.16036316636232473
POTOCKI-SHAFFER SYNDROME	0.00163132	0.16036316636232473
BRADDOCK SYNDROME	0.00163132	0.16036316636232473
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00163132	0.16036316636232473
OROFACIAL CLEFT 15	0.00163132	0.16036316636232473
SUMMITT SYNDROME	0.00163132	0.16036316636232473
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.00163132	0.16036316636232473
16P12.1P12.3 TRIPLICATION SYNDROME	0.00163132	0.16036316636232473
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00163132	0.16036316636232473
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00163132	0.16036316636232473
FRONTORHINY	0.00163132	0.16036316636232473
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00163132	0.16036316636232473
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.00163132	0.16036316636232473
LAURENCE-MOON SYNDROME	0.00163132	0.16036316636232473
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00163132	0.16036316636232473
CHIME SYNDROME	0.00163132	0.16036316636232473
KEIPERT SYNDROME	0.00163132	0.16036316636232473
ACROCALLOSAL SYNDROME; ACLS	0.00163132	0.16036316636232473
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.00163132	0.16036316636232473
CHROMOSOME 13Q14 DELETION SYNDROME	0.00163132	0.16036316636232473
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.00163132	0.16036316636232473
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00163132	0.16036316636232473
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00163132	0.16036316636232473
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00163132	0.16036316636232473
STICKLER SYNDROME	0.00163132	0.16036316636232473
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00163132	0.16036316636232473
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.00163132	0.16036316636232473
NOONAN SYNDROME 4; NS4	0.00163132	0.16036316636232473
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00163132	0.16036316636232473
SIFRIM-HITZ-WEISS SYNDROME	0.00163132	0.16036316636232473
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00163132	0.16036316636232473
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00163132	0.16036316636232473
HYPERTELORISM AND TETRALOGY OF FALLOT	0.00163132	0.16036316636232473
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.00163132	0.16036316636232473
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00163132	0.16036316636232473
PALLISTER-KILLIAN SYNDROME	0.00163132	0.16036316636232473
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00163132	0.16036316636232473
URBAN-ROGERS-MEYER SYNDROME	0.00163132	0.16036316636232473
PENOSCROTAL TRANSPOSITION	0.00163132	0.16036316636232473
MILROY DISEASE	0.00163132	0.16036316636232473
VELO-FACIAL-SKELETAL SYNDROME	0.00163132	0.16036316636232473
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00163132	0.16036316636232473
ACROCEPHALOPOLYDACTYLY	0.00163132	0.16036316636232473
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.00163132	0.16036316636232473
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00163132	0.16036316636232473
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.00163132	0.16036316636232473
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.00163132	0.16036316636232473
20Q13.33 MICRODELETION SYNDROME	0.00163132	0.16036316636232473
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.00163132	0.16036316636232473
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00163132	0.16036316636232473
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00163132	0.16036316636232473
MECKEL SYNDROME, TYPE 10; MKS10	0.00163132	0.16036316636232473
8Q21.11 MICRODELETION SYNDROME	0.00163132	0.16036316636232473
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00163132	0.16036316636232473
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.00163132	0.16036316636232473
MOSAIC MONOSOMY X	0.00163132	0.16036316636232473
PHAVER SYNDROME	0.00163132	0.16036316636232473
TURNER SYNDROME	0.00163132	0.16036316636232473
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00163132	0.16036316636232473
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.16036316636232473
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.00163132	0.16036316636232473
SHPRINTZEN OMPHALOCELE SYNDROME	0.00163132	0.16036316636232473
SCALP-EAR-NIPPLE SYNDROME; SENS	0.00163132	0.16036316636232473
EHLERS-DANLOS SYNDROME, TYPE I	0.00163132	0.16036316636232473
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.00163132	0.16036316636232473
GORLIN SYNDROME	0.00163132	0.16036316636232473
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00163132	0.16036316636232473
DUANE-RADIAL RAY SYNDROME; DRRS	0.00163132	0.16036316636232473
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00163132	0.16036316636232473
LEGIUS SYNDROME	0.00163132	0.16036316636232473
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00163132	0.16036316636232473
MEGAEPIPHYSEAL DWARFISM	0.00163132	0.16036316636232473
MONOSOMY X	0.00163132	0.16036316636232473
PTERYGIUM COLLI, ISOLATED	0.00163132	0.16036316636232473
WHITE FORELOCK WITH MALFORMATIONS	0.00163132	0.16036316636232473
DEAFNESS-HYPOGONADISM SYNDROME	0.00163132	0.16036316636232473
CHROMOSOME 17Q12 DELETION SYNDROME	0.00163132	0.16036316636232473
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.00163132	0.16036316636232473
OHDO SYNDROME	0.00163132	0.16036316636232473
SILLENCE SYNDROME	0.00163132	0.16036316636232473
SCARF SYNDROME	0.00163132	0.16036316636232473
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.00163132	0.16036316636232473
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00163132	0.16036316636232473
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.00163132	0.16036316636232473
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00163132	0.16036316636232473
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00163132	0.16036316636232473
EPICANTHUS	0.00163132	0.16036316636232473
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.16036316636232473
FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE	0.00163132	0.16036316636232473
ABRUZZO-ERICKSON SYNDROME	0.00163132	0.16036316636232473
600736 VELOFACIOSKELETAL SYNDROME	0.00163132	0.16036316636232473
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00163132	0.16036316636232473
FETAL VALPROATE SYNDROME	0.00163132	0.16036316636232473
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00163132	0.16036316636232473
FRAXE INTELLECTUAL DISABILITY	0.00163132	0.16036316636232473
CLASSICAL EHLERS-DANLOS SYNDROME	0.00163132	0.16036316636232473
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00163132	0.16036316636232473
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.001301984	0.12798854718454075
3Q29 MICRODUPLICATION SYNDROME	0.001301984	0.12798854718454075
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001301984	0.12798854718454075
MARINESCO-SJÖGREN SYNDROME	0.001301984	0.12798854718454075
16P13.11 MICRODELETION SYNDROME	0.001301984	0.12798854718454075
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.001301984	0.12798854718454075
MICRO SYNDROME	0.001301984	0.12798854718454075
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001301984	0.12798854718454075
15Q14 MICRODELETION SYNDROME	0.001301984	0.12798854718454075
HYPERTRICHOSIS CUBITI	0.001301984	0.12798854718454075
TRISOMY 17P	0.001301984	0.12798854718454075
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.001301984	0.12798854718454075
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.001301984	0.12798854718454075
MEVALONIC ACIDURIA	0.001301984	0.12798854718454075
COHEN SYNDROME	0.001301984	0.12798854718454075
2Q32Q33 MICRODELETION SYNDROME	0.001301984	0.12798854718454075
LISSENCEPHALY 2; LIS2	0.001301984	0.12798854718454075
OCULO-PALATO-CEREBRAL SYNDROME	0.001301984	0.12798854718454075
MICROPHTHALMIA, SYNDROMIC 3	0.001301984	0.12798854718454075
OROFACIODIGITAL SYNDROME TYPE 4	0.001301984	0.12798854718454075
PITT-HOPKINS SYNDROME	0.001301984	0.12798854718454075
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.001301984	0.12798854718454075
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001301984	0.12798854718454075
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.001301984	0.12798854718454075
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.001301984	0.12798854718454075
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.001301984	0.12798854718454075
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.001301984	0.12798854718454075
COG4-CDG	0.001301984	0.12798854718454075
RAINE SYNDROME	0.001301984	0.12798854718454075
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.001301984	0.12798854718454075
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.001301984	0.12798854718454075
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.001301984	0.12798854718454075
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001301984	0.12798854718454075
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.001301984	0.12798854718454075
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.001301984	0.12798854718454075
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.001301984	0.12798854718454075
%300712 CRANIOFACIOSKELETAL SYNDROME	0.001301984	0.12798854718454075
OROFACIODIGITAL SYNDROME IX; OFD9	0.001301984	0.12798854718454075
MEHMO SYNDROME; MEHMO	0.001301984	0.12798854718454075
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001301984	0.12798854718454075
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.001301984	0.12798854718454075
MIETENS SYNDROME	0.001301984	0.12798854718454075
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001301984	0.12798854718454075
GALLOWAY-MOWAT SYNDROME	0.001301984	0.12798854718454075
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.001301984	0.12798854718454075
PEDIATRIC-ONSET GRAVES DISEASE	0.001301984	0.12798854718454075
TRISOMY 9P	0.001301984	0.12798854718454075
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.001301984	0.12798854718454075
EAR-PATELLA-SHORT STATURE SYNDROME	0.001301984	0.12798854718454075
CONGENITAL VARICELLA SYNDROME	0.001301984	0.12798854718454075
PETERS-PLUS SYNDROME; PTRPLS	0.001301984	0.12798854718454075
17P11.2 MICRODUPLICATION SYNDROME	0.001301984	0.12798854718454075
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.001301984	0.12798854718454075
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.001301984	0.12798854718454075
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.001301984	0.12798854718454075
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.001301984	0.12798854718454075
MARDEN-WALKER SYNDROME	0.001301984	0.12798854718454075
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.001301984	0.12798854718454075
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.001301984	0.12798854718454075
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001301984	0.12798854718454075
8Q22.1 MICRODELETION SYNDROME	0.001301984	0.12798854718454075
OKAMOTO SYNDROME	0.001301984	0.12798854718454075
ALG11-CDG	0.001301984	0.12798854718454075
DUANE RETRACTION SYNDROME	0.001301984	0.12798854718454075
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001301984	0.12798854718454075
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.001301984	0.12798854718454075
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.001301984	0.12798854718454075
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001301984	0.12798854718454075
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.001301984	0.12798854718454075
CONGENITAL TOXOPLASMOSIS	0.001301984	0.12798854718454075
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001301984	0.12798854718454075
CEREBELLOFACIODENTAL SYNDROME	0.001301984	0.12798854718454075
HOLOPROSENCEPHALY 1; HPE1	0.001301984	0.12798854718454075
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001301984	0.12798854718454075
GALACTOSEMIA	0.001301984	0.12798854718454075
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.001301984	0.12798854718454075
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.001301984	0.12798854718454075
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.001301984	0.12798854718454075
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001301984	0.12798854718454075
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001301984	0.12798854718454075
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.001301984	0.12798854718454075
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.001301984	0.12798854718454075
WHITE-SUTTON SYNDROME; WHSUS	0.001301984	0.12798854718454075
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001301984	0.12798854718454075
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001301984	0.12798854718454075
LIG4 SYNDROME	0.001301984	0.12798854718454075
AL-RAQAD SYNDROME; ARS	0.001301984	0.12798854718454075
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001301984	0.12798854718454075
WALKER-WARBURG SYNDROME	0.001301984	0.12798854718454075
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.001301984	0.12798854718454075
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.001301984	0.12798854718454075
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.001301984	0.12798854718454075
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001301984	0.12798854718454075
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.001301984	0.12798854718454075
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001301984	0.12798854718454075
SECKEL SYNDROME 8; SCKL8	0.001301984	0.12798854718454075
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001301984	0.12798854718454075
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.001301984	0.12798854718454075
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.001301984	0.12798854718454075
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001301984	0.12798854718454075
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001301984	0.12798854718454075
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.001301984	0.12798854718454075
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.001301984	0.12798854718454075
OROFACIODIGITAL SYNDROME XIV; OFD14	0.001301984	0.12798854718454075
SLC35A2-CDG	0.001301984	0.12798854718454075
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001301984	0.12798854718454075
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.001301984	0.12798854718454075
DPAGT1-CDG	0.001301984	0.12798854718454075
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.001301984	0.12798854718454075
DYSTONIA 28, CHILDHOOD-ONSET	0.001301984	0.12798854718454075
GENITOPATELLAR SYNDROME; GTPTS	0.001301984	0.12798854718454075
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.001301984	0.12798854718454075
COFFIN-SIRIS SYNDROME 5	0.001301984	0.12798854718454075
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.001301984	0.12798854718454075
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001301984	0.12798854718454075
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.001301984	0.12798854718454075
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001301984	0.12798854718454075
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001301984	0.12798854718454075
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.001301984	0.12798854718454075
HOLOPROSENCEPHALY 3; HPE3	0.001301984	0.12798854718454075
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.001301984	0.12798854718454075
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001301984	0.12798854718454075
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001301984	0.12798854718454075
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001301984	0.12798854718454075
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.001301984	0.12798854718454075
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.001301984	0.12798854718454075
HOYERAAL-HREIDARSSON SYNDROME	0.001301984	0.12798854718454075
LISSENCEPHALY 8; LIS8	0.001301984	0.12798854718454075
HEART AND BRAIN MALFORMATION SYNDROME	0.001301984	0.12798854718454075
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.001301984	0.12798854718454075
GENITOPATELLAR SYNDROME	0.001301984	0.12798854718454075
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.001301984	0.12798854718454075
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001301984	0.12798854718454075
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.001301984	0.12798854718454075
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.001301984	0.12798854718454075
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.001301984	0.12798854718454075
CRANIOSYNOSTOSIS 6; CRS6	0.001301984	0.12798854718454075
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.001301984	0.12798854718454075
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.001301984	0.12798854718454075
ROIFMAN SYNDROME; RFMN	0.001301984	0.12798854718454075
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.001301984	0.12798854718454075
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001301984	0.12798854718454075
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.001301984	0.12798854718454075
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001301984	0.12798854718454075
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.001301984	0.12798854718454075
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.001301984	0.12798854718454075
SECKEL SYNDROME 9; SCKL9	0.001301984	0.12798854718454075
BRESEK SYNDROME	0.001301984	0.12798854718454075
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001301984	0.12798854718454075
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.001301984	0.12798854718454075
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001301984	0.12798854718454075
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.001301984	0.12798854718454075
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001301984	0.12798854718454075
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.001301984	0.12798854718454075
LISSENCEPHALY 4	0.001301984	0.12798854718454075
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001301984	0.12798854718454075
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.001301984	0.12798854718454075
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001301984	0.12798854718454075
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.001301984	0.12798854718454075
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001301984	0.12798854718454075
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.001301984	0.12798854718454075
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.001301984	0.12798854718454075
ADAMS-OLIVER SYNDROME 1; AOS1	0.001301984	0.12798854718454075
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001301984	0.12798854718454075
ADAMS-OLIVER SYNDROME 2; AOS2	0.001301984	0.12798854718454075
CHROMOSOME 16P13.3 DELETION SYNDROME	0.001301984	0.12798854718454075
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.001301984	0.12798854718454075
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.001301984	0.12798854718454075
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.001301984	0.12798854718454075
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.001301984	0.12798854718454075
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.001301984	0.12798854718454075
OROFACIODIGITAL SYNDROME TYPE 14	0.001301984	0.12798854718454075
AICARDI-GOUTIERES SYNDROME 5	0.001301984	0.12798854718454075
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001301984	0.12798854718454075
PHACE SYNDROME	0.001301984	0.12798854718454075
GLASS SYNDROME	0.001301984	0.12798854718454075
MOSAIC TRISOMY 9	0.001301984	0.12798854718454075
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001301984	0.12798854718454075
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.001301984	0.12798854718454075
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.001301984	0.12798854718454075
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.001301984	0.12798854718454075
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.001301984	0.12798854718454075
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.001301984	0.12798854718454075
BETA-UREIDOPROPIONASE DEFICIENCY	0.001301984	0.12798854718454075
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.001301984	0.12798854718454075
XQ28 (MECP2) DUPLICATION	0.001301984	0.12798854718454075
FORSYTHE-WAKELING SYNDROME; FWS	0.001301984	0.12798854718454075
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.001301984	0.12798854718454075
CHROMOSOME 19P13.13 DELETION SYNDROME	0.001301984	0.12798854718454075
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.001301984	0.12798854718454075
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.001301984	0.12798854718454075
MEVALONIC ACIDURIA; MEVA	0.001301984	0.12798854718454075
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.001301984	0.12798854718454075
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.001301984	0.12798854718454075
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001301984	0.12798854718454075
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001301984	0.12798854718454075
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.001301984	0.12798854718454075
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001301984	0.12798854718454075
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001301984	0.12798854718454075
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.001301984	0.12798854718454075
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001301984	0.12798854718454075
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.001301984	0.12798854718454075
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.001301984	0.12798854718454075
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001301984	0.12798854718454075
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001301984	0.12798854718454075
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.001301984	0.12798854718454075
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.001301984	0.12798854718454075
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001301984	0.12798854718454075
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001301984	0.12798854718454075
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001301984	0.12798854718454075
TOWNES-BROCKS SYNDROME 1; TBS1	0.001301984	0.12798854718454075
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.001301984	0.12798854718454075
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001301984	0.12798854718454075
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.001301984	0.12798854718454075
EMANUEL SYNDROME	0.001301984	0.12798854718454075
COFFIN-SIRIS SYNDROME 3; CSS3	0.001301984	0.12798854718454075
COFFIN-SIRIS SYNDROME 4; CSS4	0.001301984	0.12798854718454075
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001301984	0.12798854718454075
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001301984	0.12798854718454075
DISTAL MONOSOMY 12Q	0.001301984	0.12798854718454075
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.001301984	0.12798854718454075
ALAZAMI SYNDROME; ALAZS	0.001301984	0.12798854718454075
ADAMS-OLIVER SYNDROME 3; AOS3	0.001301984	0.12798854718454075
SSR4-CDG	0.001301984	0.12798854718454075
STT3B-CDG	0.001301984	0.12798854718454075
STT3A-CDG	0.001301984	0.12798854718454075
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.001301984	0.12798854718454075
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.001301984	0.12798854718454075
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001301984	0.12798854718454075
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.001301984	0.12798854718454075
MYHRE SYNDROME	0.001301984	0.12798854718454075
KABUKI SYNDROME 1	0.001301984	0.12798854718454075
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001301984	0.12798854718454075
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.001301984	0.12798854718454075
PETERS PLUS SYNDROME	0.001301984	0.12798854718454075
LOWRY-MACLEAN SYNDROME	0.001301984	0.12798854718454075
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.001301984	0.12798854718454075
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.001301984	0.12798854718454075
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001301984	0.12798854718454075
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.001301984	0.12798854718454075
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.001301984	0.12798854718454075
MARINESCO-SJOGREN SYNDROME; MSS	0.001301984	0.12798854718454075
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.001301984	0.12798854718454075
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.001301984	0.12798854718454075
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.001301984	0.12798854718454075
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001301984	0.12798854718454075
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.001301984	0.12798854718454075
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.001301984	0.12798854718454075
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.001301984	0.12798854718454075
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.001301984	0.12798854718454075
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.001301984	0.12798854718454075
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.001301984	0.12798854718454075
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001301984	0.12798854718454075
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.001301984	0.12798854718454075
JABERI-ELAHI SYNDROME; JABELS	0.001301984	0.12798854718454075
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.001301984	0.12798854718454075
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.001301984	0.12798854718454075
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.001301984	0.12798854718454075
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001301984	0.12798854718454075
CHROMOSOME 1P35 DELETION SYNDROME	0.001301984	0.12798854718454075
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.001301984	0.12798854718454075
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.001301984	0.12798854718454075
KBG SYNDROME	0.001301984	0.12798854718454075
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.001301984	0.12798854718454075
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.001301984	0.12798854718454075
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.001301984	0.12798854718454075
PENTASOMY X	0.001301984	0.12798854718454075
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.001301984	0.12798854718454075
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.001301984	0.12798854718454075
ROBERTS SYNDROME	0.001301984	0.12798854718454075
2Q37 MICRODELETION SYNDROME	0.001301984	0.12798854718454075
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001301984	0.12798854718454075
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001301984	0.12798854718454075
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.001301984	0.12798854718454075
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.001301984	0.12798854718454075
RUVALCABA SYNDROME	0.001301984	0.12798854718454075
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.001301984	0.12798854718454075
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.001301984	0.12798854718454075
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.001301984	0.12798854718454075
DUPLICATION OF THE PITUITARY GLAND	0.001301984	0.12798854718454075
SAY-BARBER-MILLER SYNDROME	0.001301984	0.12798854718454075
PELIZAEUS-MERZBACHER DISEASE	0.001301984	0.12798854718454075
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.001301984	0.12798854718454075
TURNPENNY-FRY SYNDROME; TPFS	0.001301984	0.12798854718454075
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001301984	0.12798854718454075
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001301984	0.12798854718454075
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.001301984	0.12798854718454075
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001301984	0.12798854718454075
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.001301984	0.12798854718454075
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.001301984	0.12798854718454075
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001301984	0.12798854718454075
WIEACKER-WOLFF SYNDROME	0.001301984	0.12798854718454075
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001301984	0.12798854718454075
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.001301984	0.12798854718454075
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.001301984	0.12798854718454075
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.001301984	0.12798854718454075
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.001301984	0.12798854718454075
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.001301984	0.12798854718454075
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001301984	0.12798854718454075
RING CHROMOSOME 12 SYNDROME	0.001301984	0.12798854718454075
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001301984	0.12798854718454075
FILIPPI SYNDROME	0.001301984	0.12798854718454075
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001301984	0.12798854718454075
MENTAL RETARDATION, X-LINKED 106; MRX106	0.001301984	0.12798854718454075
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.001301984	0.12798854718454075
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001301984	0.12798854718454075
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001301984	0.12798854718454075
CRANIOTELENCEPHALIC DYSPLASIA	0.001301984	0.12798854718454075
CLASSIC PHENYLKETONURIA	0.001301984	0.12798854718454075
TONNE-KALSCHEUER SYNDROME; TOKAS	0.001301984	0.12798854718454075
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001301984	0.12798854718454075
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001301984	0.12798854718454075
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001301984	0.12798854718454075
DISTAL MONOSOMY 15Q	0.001301984	0.12798854718454075
ALG1-CDG	0.001301984	0.12798854718454075
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.001301984	0.12798854718454075
ALG3-CDG	0.001301984	0.12798854718454075
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.001301984	0.12798854718454075
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001301984	0.12798854718454075
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.001301984	0.12798854718454075
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001301984	0.12798854718454075
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001301984	0.12798854718454075
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.001301984	0.12798854718454075
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001301984	0.12798854718454075
17Q11.2 MICRODUPLICATION SYNDROME	0.001301984	0.12798854718454075
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.001301984	0.12798854718454075
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.001301984	0.12798854718454075
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001301984	0.12798854718454075
MACDERMOT-WINTER SYNDROME	0.001301984	0.12798854718454075
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.001301984	0.12798854718454075
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.001301984	0.12798854718454075
HOLOPROSENCEPHALY 2; HPE2	0.001301984	0.12798854718454075
KLEEFSTRA SYNDROME 2; KLEFS2	0.001301984	0.12798854718454075
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001301984	0.12798854718454075
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001301984	0.12798854718454075
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.001301984	0.12798854718454075
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001301984	0.12798854718454075
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001301984	0.12798854718454075
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001301984	0.12798854718454075
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.001301984	0.12798854718454075
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.001301984	0.12798854718454075
MUCOLIPIDOSIS IV; ML4	0.001301984	0.12798854718454075
OPTIC ATROPHY 11; OPA11	0.001301984	0.12798854718454075
NEU-LAXOVA SYNDROME	0.00075643	0.07435911404963669
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.00075643	0.07435911404963669
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.00075643	0.07435911404963669
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00075643	0.07435911404963669
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.00075643	0.07435911404963669
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.00075643	0.07435911404963669
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00075643	0.07435911404963669
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.00075643	0.07435911404963669
MICROCEPHALY-CARDIOMYOPATHY	0.00075643	0.07435911404963669
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00075643	0.07435911404963669
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.00075643	0.07435911404963669
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.00075643	0.07435911404963669
FANCONI ANEMIA	0.00075643	0.07435911404963669
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.00075643	0.07435911404963669
POLAND SYNDROME	0.00075643	0.07435911404963669
LEUKOCYTE ADHESION DEFICIENCY	0.00075643	0.07435911404963669
MEIER-GORLIN SYNDROME 1; MGORS1	0.00075643	0.07435911404963669
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.00075643	0.07435911404963669
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.00075643	0.07435911404963669
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00075643	0.07435911404963669
RENAL TUBULAR DYSGENESIS	0.00075643	0.07435911404963669
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00075643	0.07435911404963669
OLIVER SYNDROME	0.00075643	0.07435911404963669
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00075643	0.07435911404963669
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.00075643	0.07435911404963669
OCULOAURICULOFRONTONASAL SYNDROME	0.00075643	0.07435911404963669
NIJMEGEN BREAKAGE SYNDROME	0.00075643	0.07435911404963669
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00075643	0.07435911404963669
ENCEPHALOMALACIA, MULTILOCULAR	0.00075643	0.07435911404963669
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00075643	0.07435911404963669
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00075643	0.07435911404963669
PSEUDOPROGERIA SYNDROME	0.00075643	0.07435911404963669
OROFACIODIGITAL SYNDROME TYPE 5	0.00075643	0.07435911404963669
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00075643	0.07435911404963669
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00075643	0.07435911404963669
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00075643	0.07435911404963669
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00075643	0.07435911404963669
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00075643	0.07435911404963669
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00075643	0.07435911404963669
CONGENITAL RUBELLA SYNDROME	0.00075643	0.07435911404963669
MMEP SYNDROME	0.00075643	0.07435911404963669
XK APROSENCEPHALY SYNDROME	0.00075643	0.07435911404963669
WORSTER-DROUGHT SYNDROME	0.00075643	0.07435911404963669
LAMBOTTE SYNDROME	0.00075643	0.07435911404963669
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.00075643	0.07435911404963669
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00075643	0.07435911404963669
3MC SYNDROME 1	0.00075643	0.07435911404963669
BANGSTAD SYNDROME	0.00075643	0.07435911404963669
MICROFORM HOLOPROSENCEPHALY	0.00075643	0.07435911404963669
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.00075643	0.07435911404963669
OCULOPALATOCEREBRAL SYNDROME	0.00075643	0.07435911404963669
BOWEN-CONRADI SYNDROME	0.00075643	0.07435911404963669
WEAVER-WILLIAMS SYNDROME	0.00075643	0.07435911404963669
HUMERO-RADIAL SYNOSTOSIS	0.00075643	0.07435911404963669
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.00075643	0.07435911404963669
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00075643	0.07435911404963669
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00075643	0.07435911404963669
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO ZNF335 DEFICIENCY	0.00075643	0.07435911404963669
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.00075643	0.07435911404963669
TYROSINEMIA TYPE 2	0.00075643	0.07435911404963669
BLOOM SYNDROME	0.00075643	0.07435911404963669
JOHANSON-BLIZZARD SYNDROME; JBS	0.00075643	0.07435911404963669
STROMME SYNDROME; STROMS	0.00075643	0.07435911404963669
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.00075643	0.07435911404963669
CHARGE SYNDROME	0.00075643	0.07435911404963669
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.00075643	0.07435911404963669
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.00075643	0.07435911404963669
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00075643	0.07435911404963669
TETRAPLOIDY	0.00075643	0.07435911404963669
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00075643	0.07435911404963669
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.00075643	0.07435911404963669
RHIZOMELIC SYNDROME, URBACH TYPE	0.00075643	0.07435911404963669
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.00075643	0.07435911404963669
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.00075643	0.07435911404963669
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00075643	0.07435911404963669
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00075643	0.07435911404963669
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00075643	0.07435911404963669
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00075643	0.07435911404963669
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00075643	0.07435911404963669
SATOYOSHI SYNDROME	0.00075643	0.07435911404963669
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.00075643	0.07435911404963669
GERODERMA OSTEODYSPLASTICUM; GO	0.00075643	0.07435911404963669
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00075643	0.07435911404963669
SECKEL SYNDROME 1; SCKL1	0.00075643	0.07435911404963669
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.00075643	0.07435911404963669
COHEN SYNDROME	0.00075643	0.07435911404963669
MECKEL SYNDROME, TYPE 1; MKS1	0.00075643	0.07435911404963669
STIMMLER SYNDROME	0.00075643	0.07435911404963669
ERYTHROKERATODERMIA VARIABILIS	0.00075643	0.07435911404963669
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.00075643	0.07435911404963669
HALLERMANN-STREIFF SYNDROME; HSS	0.00075643	0.07435911404963669
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.00075643	0.07435911404963669
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.00075643	0.07435911404963669
ROIFMAN SYNDROME	0.00075643	0.07435911404963669
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.00075643	0.07435911404963669
MOWAT-WILSON SYNDROME; MOWS	0.00075643	0.07435911404963669
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00075643	0.07435911404963669
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00075643	0.07435911404963669
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00075643	0.07435911404963669
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00075643	0.07435911404963669
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.07435911404963669
WOLF-HIRSCHHORN SYNDROME	0.00075643	0.07435911404963669
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.00075643	0.07435911404963669
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00075643	0.07435911404963669
MEIER-GORLIN SYNDROME 8; MGORS8	0.00075643	0.07435911404963669
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00075643	0.07435911404963669
601453 TRICHODENTAL DYSPLASIA	0.00075643	0.07435911404963669
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00075643	0.07435911404963669
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00075643	0.07435911404963669
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.00075643	0.07435911404963669
MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18	0.00075643	0.07435911404963669
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.00075643	0.07435911404963669
LARYNGEAL ABDUCTOR PARALYSIS	0.00075643	0.07435911404963669
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00075643	0.07435911404963669
SECKEL SYNDROME 10; SCKL10	0.00075643	0.07435911404963669
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.00075643	0.07435911404963669
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.00075643	0.07435911404963669
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00075643	0.07435911404963669
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00075643	0.07435911404963669
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00075643	0.07435911404963669
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.00075643	0.07435911404963669
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.00075643	0.07435911404963669
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00075643	0.07435911404963669
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00075643	0.07435911404963669
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00075643	0.07435911404963669
MENKES DISEASE	0.00075643	0.07435911404963669
BARDET-BIEDL SYNDROME 20	0.00075643	0.07435911404963669
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.00075643	0.07435911404963669
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00075643	0.07435911404963669
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00075643	0.07435911404963669
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.00075643	0.07435911404963669
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00075643	0.07435911404963669
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.00075643	0.07435911404963669
CAMOS SYNDROME	0.00075643	0.07435911404963669
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.00075643	0.07435911404963669
SJÖGREN-LARSSON SYNDROME	0.00075643	0.07435911404963669
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00075643	0.07435911404963669
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00075643	0.07435911404963669
HYPERREFLEXIA	0.00075643	0.07435911404963669
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.00075643	0.07435911404963669
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00075643	0.07435911404963669
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.00075643	0.07435911404963669
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00075643	0.07435911404963669
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00075643	0.07435911404963669
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00075643	0.07435911404963669
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00075643	0.07435911404963669
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.00075643	0.07435911404963669
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00075643	0.07435911404963669
PRIMARY CUTIS VERTICIS GYRATA	0.00075643	0.07435911404963669
WARBURG MICRO SYNDROME 1	0.00075643	0.07435911404963669
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.00075643	0.07435911404963669
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.00075643	0.07435911404963669
CYCLIC VOMITING SYNDROME	0.00075643	0.07435911404963669
PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	0.00075643	0.07435911404963669
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00075643	0.07435911404963669
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00075643	0.07435911404963669
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.00075643	0.07435911404963669
RUVALCABA SYNDROME	0.00075643	0.07435911404963669
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00075643	0.07435911404963669
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.00075643	0.07435911404963669
PAINE SYNDROME	0.00075643	0.07435911404963669
MICROPHTHALMIA, SYNDROMIC 1	0.00075643	0.07435911404963669
NEVUS COMEDONICUS SYNDROME	0.00075643	0.07435911404963669
NIJMEGEN BREAKAGE SYNDROME	0.00075643	0.07435911404963669
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.07435911404963669
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.00075643	0.07435911404963669
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00075643	0.07435911404963669
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00075643	0.07435911404963669
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00075643	0.07435911404963669
ANGELMAN SYNDROME	0.00075643	0.07435911404963669
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00075643	0.07435911404963669
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00075643	0.07435911404963669
IMMUNODEFICIENCY 55; IMD55	0.00075643	0.07435911404963669
ATAXIA-PANCYTOPENIA SYNDROME	0.00075643	0.07435911404963669
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.00075643	0.07435911404963669
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00075643	0.07435911404963669
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00075643	0.07435911404963669
VERVERI-BRADY SYNDROME; VERBRAS	0.00075643	0.07435911404963669
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.00075643	0.07435911404963669
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.00075643	0.07435911404963669
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.00075643	0.07435911404963669
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.00075643	0.07435911404963669
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00075643	0.07435911404963669
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.00075643	0.07435911404963669
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00075643	0.07435911404963669
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00075643	0.07435911404963669
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00075643	0.07435911404963669
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.00075643	0.07435911404963669
MEIER-GORLIN SYNDROME 6; MGORS6	0.00075643	0.07435911404963669
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.00075643	0.07435911404963669
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.00075643	0.07435911404963669
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.00075643	0.07435911404963669
15Q24 RECURRENT MICRODELETION SYNDROME	0.00075643	0.07435911404963669
MEIER-GORLIN SYNDROME 2; MGORS2	0.00075643	0.07435911404963669
MEIER-GORLIN SYNDROME 3; MGORS3	0.00075643	0.07435911404963669
2P15-16.1 MICRODELETION SYNDROME	0.00075643	0.07435911404963669
SECKEL SYNDROME 5; SCKL5	0.00075643	0.07435911404963669
XFE PROGEROID SYNDROME; XFEPS	0.00075643	0.07435911404963669
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00075643	0.07435911404963669
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00075643	0.07435911404963669
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.00075643	0.07435911404963669
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.00075643	0.07435911404963669
PERRAULT SYNDROME 3	0.00075643	0.07435911404963669
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00075643	0.07435911404963669
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.00075643	0.07435911404963669
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00075643	0.07435911404963669
FEINGOLD SYNDROME 2; FGLDS2	0.00075643	0.07435911404963669
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00075643	0.07435911404963669
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00075643	0.07435911404963669
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00075643	0.07435911404963669
SECKEL SYNDROME 4	0.00075643	0.07435911404963669
1Q21.1 RECURRENT MICRODELETION (SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.00075643	0.07435911404963669
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.00075643	0.07435911404963669
ANGELMAN SYNDROME (TYPE 2)	0.00075643	0.07435911404963669
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.00075643	0.07435911404963669
CRI DU CHAT SYNDROME (5P DELETION)	0.00075643	0.07435911404963669
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.00075643	0.07435911404963669
ERMINE PHENOTYPE	0.00075643	0.07435911404963669
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00075643	0.07435911404963669
MILLER-DIEKER SYNDROME (MDS)	0.00075643	0.07435911404963669
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00075643	0.07435911404963669
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.00075643	0.07435911404963669
LISSENCEPHALY 3; LIS3	0.00075643	0.07435911404963669
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.00075643	0.07435911404963669
FACIOCARDIOMELIC SYNDROME	0.00075643	0.07435911404963669
ANGELMAN SYNDROME (TYPE 1)	0.00075643	0.07435911404963669
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00075643	0.07435911404963669
PAGOD SYNDROME	0.00075643	0.07435911404963669
FRONTONASAL DYSPLASIA 2; FND2	0.00075643	0.07435911404963669
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.00075643	0.07435911404963669
MECKEL SYNDROME, TYPE 4; MKS4	0.00075643	0.07435911404963669
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00075643	0.07435911404963669
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.00075643	0.07435911404963669
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.00075643	0.07435911404963669
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00075643	0.07435911404963669
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.00075643	0.07435911404963669
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.00075643	0.07435911404963669
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.00075643	0.07435911404963669
KLIPPEL-TRÉNAUNAY SYNDROME	0.00075643	0.07435911404963669
WAARDENBURG SYNDROME TYPE 3	0.00075643	0.07435911404963669
WAGR SYNDROME	0.00075643	0.07435911404963669
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00075643	0.07435911404963669
MECKEL SYNDROME 12; MKS12	0.00075643	0.07435911404963669
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00075643	0.07435911404963669
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.00075643	0.07435911404963669
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.00075643	0.07435911404963669
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00075643	0.07435911404963669
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00075643	0.07435911404963669
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00075643	0.07435911404963669
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00075643	0.07435911404963669
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.00075643	0.07435911404963669
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00075643	0.07435911404963669
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00075643	0.07435911404963669
NEU-LAXOVA SYNDROME 2; NLS2	0.00075643	0.07435911404963669
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.00075643	0.07435911404963669
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00075643	0.07435911404963669
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.00075643	0.07435911404963669
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.00075643	0.07435911404963669
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00075643	0.07435911404963669
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00075643	0.07435911404963669
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00075643	0.07435911404963669
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.00075643	0.07435911404963669
ACROCRANIOFACIAL DYSOSTOSIS	0.00075643	0.07435911404963669
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00075643	0.07435911404963669
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00075643	0.07435911404963669
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.00075643	0.07435911404963669
RENIER-GABREELS-JASPER SYNDROME	0.00075643	0.07435911404963669
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00075643	0.07435911404963669
BRANCHIOOCULOFACIAL SYNDROME	0.00075643	0.07435911404963669
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00075643	0.07435911404963669
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00075643	0.07435911404963669
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00075643	0.07435911404963669
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.00075643	0.07435911404963669
GAUCHER DISEASE, PERINATAL LETHAL	0.00075643	0.07435911404963669
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.00075643	0.07435911404963669
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00075643	0.07435911404963669
ANONYCHIA-MICROCEPHALY SYNDROME	0.00075643	0.07435911404963669
COCKAYNE SYNDROME	0.00075643	0.07435911404963669
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.00075643	0.07435911404963669
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.00075643	0.07435911404963669
SHPRINTZEN-GOLDBERG SYNDROME	0.00075643	0.07435911404963669
HYPO- AND HYPERMELANOTIC CUTANEOUS MACULES-RETARDED GROWTH-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.07435911404963669
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.00075643	0.07435911404963669
SEVERE COMBINED IMMUNODEFICIENCY	0.00075643	0.07435911404963669
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.00075643	0.07435911404963669
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.00075643	0.07435911404963669
MENTAL RETARDATION, X-LINKED 63	0.00075643	0.07435911404963669
FETAL METHYLMERCURY SYNDROME	0.00075643	0.07435911404963669
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00075643	0.07435911404963669
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00075643	0.07435911404963669
DIABETIC EMBRYOPATHY	0.00075643	0.07435911404963669
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.00075643	0.07435911404963669
FILIPPI SYNDROME; FLPIS	0.00075643	0.07435911404963669
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00075643	0.07435911404963669
LOWRY-WOOD SYNDROME	0.00075643	0.07435911404963669
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00075643	0.07435911404963669
DYSOSTOSIS, STANESCU TYPE	0.00075643	0.07435911404963669
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00075643	0.07435911404963669
MICROPHTHALMIA, LENZ TYPE	0.00075643	0.07435911404963669
ISOLATED OSTEOPOIKILOSIS	0.00075643	0.07435911404963669
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00075643	0.07435911404963669
MECKEL SYNDROME	0.00075643	0.07435911404963669
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.00075643	0.07435911404963669
MICROCEPHALY-ALBINISM-DIGITAL ANOMALIES SYNDROME	0.00075643	0.07435911404963669
CERNUNNOS-XLF DEFICIENCY	0.00075643	0.07435911404963669
DISTAL TRISOMY 15Q	0.00075643	0.07435911404963669
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00075643	0.07435911404963669
TRISOMY 18P	0.00075643	0.07435911404963669
VELOCARDIOFACIAL SYNDROME	0.00075643	0.07435911404963669
TRISOMY 4P	0.00075643	0.07435911404963669
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00075643	0.07435911404963669
CHROMOSOME XP11.3 DELETION SYNDROME	0.00075643	0.07435911404963669
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00075643	0.07435911404963669
TEEBI-SHALTOUT SYNDROME; TBSH	0.00075643	0.07435911404963669
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.00075643	0.07435911404963669
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00075643	0.07435911404963669
LEPRECHAUNISM	0.00075643	0.07435911404963669
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.00075643	0.07435911404963669
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.00075643	0.07435911404963669
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.00075643	0.07435911404963669
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00075643	0.07435911404963669
KERATOSIS FOLLICULARIS-DWARFISM-CEREBRAL ATROPHY SYNDROME	0.00075643	0.07435911404963669
SANJAD-SAKATI SYNDROME	0.00075643	0.07435911404963669
KABUKI SYNDROME	0.00075643	0.07435911404963669
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.00075643	0.07435911404963669
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.00075643	0.07435911404963669
JUNG SYNDROME	0.00075643	0.07435911404963669
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00075643	0.07435911404963669
5Q35 MICRODUPLICATION SYNDROME	0.00075643	0.07435911404963669
JUBERG-HAYWARD SYNDROME	0.00075643	0.07435911404963669
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.00075643	0.07435911404963669
JOHNSON NEUROECTODERMAL SYNDROME	0.00075643	0.07435911404963669
JOHANSON-BLIZZARD SYNDROME	0.00075643	0.07435911404963669
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.00075643	0.07435911404963669
19Q13.11 MICRODELETION SYNDROME	0.00075643	0.07435911404963669
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00075643	0.07435911404963669
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.00075643	0.07435911404963669
ACHALASIA-MICROCEPHALY SYNDROME	0.00075643	0.07435911404963669
LARYNGEAL ABDUCTOR PARALYSIS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.07435911404963669
FRASER SYNDROME	0.00075643	0.07435911404963669
FRYNS-SMEETS-THIRY SYNDROME	0.00075643	0.07435911404963669
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.00075643	0.07435911404963669
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.07435911404963669
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.00075643	0.07435911404963669
GENITOPALATOCARDIAC SYNDROME	0.00075643	0.07435911404963669
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00075643	0.07435911404963669
HALLERMANN-STREIFF SYNDROME	0.00075643	0.07435911404963669
HARROD SYNDROME	0.00075643	0.07435911404963669
ADDUCTED THUMBS SYNDROME	0.00075643	0.07435911404963669
DE SANCTIS-CACCHIONE SYNDROME	0.00075643	0.07435911404963669
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00075643	0.07435911404963669
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00075643	0.07435911404963669
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.00075643	0.07435911404963669
NON-DISTAL TRISOMY 10Q	0.00075643	0.07435911404963669
AICARDI SYNDROME; AIC	0.00075643	0.07435911404963669
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00075643	0.07435911404963669
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.00075643	0.07435911404963669
9Q33.3Q34.11 MICRODELETION SYNDROME	0.00075643	0.07435911404963669
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.00075643	0.07435911404963669
FAMILIAL VISCERAL MYOPATHY	0.00075643	0.07435911404963669
PSEUDOTRISOMY 13 SYNDROME	0.00075643	0.07435911404963669
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00075643	0.07435911404963669
207790 ARACHNOID CYSTS, INTRACRANIAL	0.00075643	0.07435911404963669
SYMMETRICAL THALAMIC CALCIFICATIONS	0.00075643	0.07435911404963669
MASA SYNDROME	0.00075643	0.07435911404963669
MOYNAHAN SYNDROME	0.00075643	0.07435911404963669
SUPRABULBAR PARESIS, CONGENITAL	0.00075643	0.07435911404963669
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.00075643	0.07435911404963669
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.00075643	0.07435911404963669
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00075643	0.07435911404963669
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00075643	0.07435911404963669
PHENYLKETONURIA	0.00075643	0.07435911404963669
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00075643	0.07435911404963669
SCHISIS ASSOCIATION	0.00075643	0.07435911404963669
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00075643	0.07435911404963669
COG5-CDG	0.00075643	0.07435911404963669
APHALANGY-SYNDACTYLY-MICROCEPHALY SYNDROME	0.00075643	0.07435911404963669
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.00075643	0.07435911404963669
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00075643	0.07435911404963669
INCONTINENTIA PIGMENTI; IP	0.00075643	0.07435911404963669
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.00075643	0.07435911404963669
FEINGOLD SYNDROME	0.00075643	0.07435911404963669
BARTSOCAS-PAPAS SYNDROME	0.00075643	0.07435911404963669
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.00075643	0.07435911404963669
BLOOM SYNDROME	0.00075643	0.07435911404963669
BONNEMANN-MEINECKE-REICH SYNDROME	0.00075643	0.07435911404963669
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.00075643	0.07435911404963669
FOCAL DERMAL HYPOPLASIA; FDH	0.00075643	0.07435911404963669
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.00075643	0.07435911404963669
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00075643	0.07435911404963669
CEREBROCOSTOMANDIBULAR SYNDROME	0.00075643	0.07435911404963669
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.00075643	0.07435911404963669
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.00075643	0.07435911404963669
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.00075643	0.07435911404963669
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00075643	0.07435911404963669
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.00075643	0.07435911404963669
DISTAL MONOSOMY 7Q36	0.00075643	0.07435911404963669
DISTAL MONOSOMY 17Q	0.00075643	0.07435911404963669
DISTAL MONOSOMY 13Q	0.00075643	0.07435911404963669
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.00075643	0.07435911404963669
MENTAL RETARDATION, X-LINKED 102	0.00075643	0.07435911404963669
ANE SYNDROME	0.00075643	0.07435911404963669
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.00075643	0.07435911404963669
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.00075643	0.07435911404963669
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.00075643	0.07435911404963669
ROBERTS SYNDROME; RBS	0.00075643	0.07435911404963669
CRANIOFRONTONASAL DYSPLASIA	0.00075643	0.07435911404963669
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00075643	0.07435911404963669
RING CHROMOSOME 1 SYNDROME	0.00075643	0.07435911404963669
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00075643	0.07435911404963669
RHIZOMELIC SYNDROME	0.00075643	0.07435911404963669
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00075643	0.07435911404963669
OTOMANDIBULAR SYNDROME	0.00075643	0.07435911404963669
ZEBRA BODY MYOPATHY	0.000545554	0.05362943313490408
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.05362943313490408
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.000545554	0.05362943313490408
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05362943313490408
PERMANENT NEONATAL DIABETES MELLITUS	0.000545554	0.05362943313490408
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.000545554	0.05362943313490408
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.05362943313490408
TRANSIENT NEONATAL DIABETES MELLITUS	0.000545554	0.05362943313490408
COG2-CDG	0.000545554	0.05362943313490408
RIGID SPINE SYNDROME	0.000545554	0.05362943313490408
THYROID ECTOPIA	0.000545554	0.05362943313490408
SPINOCEREBELLAR ATAXIA TYPE 7	0.000545554	0.05362943313490408
TRANSKETOLASE DEFICIENCY	0.000545554	0.05362943313490408
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.05362943313490408
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.05362943313490408
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000545554	0.05362943313490408
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.000545554	0.05362943313490408
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.000545554	0.05362943313490408
ALSTROM SYNDROME; ALMS	0.000545554	0.05362943313490408
PITUITARY STALK INTERRUPTION SYNDROME	0.000545554	0.05362943313490408
ATHYREOSIS	0.000545554	0.05362943313490408
DISTAL MONOSOMY 19P13.3	0.000545554	0.05362943313490408
AUSTRALIA ANTIGEN	0.000545554	0.05362943313490408
ARGININOSUCCINIC ACIDURIA	0.000545554	0.05362943313490408
TEMTAMY SYNDROME; TEMTYS	0.000545554	0.05362943313490408
ANGELMAN SYNDROME	0.000545554	0.05362943313490408
SPINOCEREBELLAR ATAXIA TYPE 13	0.000545554	0.05362943313490408
THYROID HYPOPLASIA	0.000545554	0.05362943313490408
RECOMBINANT 8 SYNDROME	0.000545554	0.05362943313490408
THYROID HEMIAGENESIS	0.000545554	0.05362943313490408
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.05362943313490408
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.000545554	0.05362943313490408
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.05362943313490408
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.000545554	0.05362943313490408
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.05362943313490408
BARDET-BIEDL SYNDROME 1; BBS1	0.000545554	0.05362943313490408
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.05362943313490408
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.000545554	0.05362943313490408
FAMILIAL THYROID DYSHORMONOGENESIS	0.000545554	0.05362943313490408
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.000545554	0.05362943313490408
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.000545554	0.05362943313490408
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.000545554	0.05362943313490408
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.05362943313490408
8P23.1 DUPLICATION SYNDROME	0.000545554	0.05362943313490408
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.000545554	0.05362943313490408
HURLER SYNDROME	0.000545554	0.05362943313490408
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.05362943313490408
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.05362943313490408
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.05362943313490408
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.05362943313490408
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.05362943313490408
6Q TERMINAL DELETION SYNDROME	0.000545554	0.05362943313490408
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.05362943313490408
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.05362943313490408
INFANTILE REFSUM DISEASE	0.000545554	0.05362943313490408
DIGEORGE SYNDROME; DGS	0.000545554	0.05362943313490408
MEDULLOBLASTOMA	0.000545554	0.05362943313490408
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.000545554	0.05362943313490408
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.05362943313490408
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.000545554	0.05362943313490408
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.000545554	0.05362943313490408
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.000545554	0.05362943313490408
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.05362943313490408
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.000545554	0.05362943313490408
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000545554	0.05362943313490408
WOLMAN DISEASE	0.000545554	0.05362943313490408
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.000545554	0.05362943313490408
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.05362943313490408
CURRARINO SYNDROME	0.000545554	0.05362943313490408
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.05362943313490408
NARP SYNDROME	0.000545554	0.05362943313490408
ALSTRÖM SYNDROME	0.000545554	0.05362943313490408
LEBER CONGENITAL AMAUROSIS	0.000545554	0.05362943313490408
SEPTOOPTIC DYSPLASIA	0.000545554	0.05362943313490408
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.05362943313490408
PALLISTER-HALL SYNDROME	0.000545554	0.05362943313490408
RECOMBINANT CHROMOSOME 8 SYNDROME	0.000545554	0.05362943313490408
3C SYNDROME	0.000545554	0.05362943313490408
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.05362943313490408
PRADER-WILLI SYNDROME; PWS	0.000545554	0.05362943313490408
NETHERTON SYNDROME	0.000545554	0.05362943313490408
CHAR SYNDROME	0.000545554	0.05362943313490408
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.000545554	0.05362943313490408
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.05362943313490408
PELGER-HUET ANOMALY; PHA	0.000545554	0.05362943313490408
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.000545554	0.05362943313490408
CHAR SYNDROME	0.000545554	0.05362943313490408
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.05362943313490408
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.05362943313490408
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.000545554	0.05362943313490408
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05362943313490408
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000545554	0.05362943313490408
TREACHER-COLLINS SYNDROME	0.000545554	0.05362943313490408
SIALIDOSIS TYPE 2	0.000545554	0.05362943313490408
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.000545554	0.05362943313490408
COACH SYNDROME	0.000545554	0.05362943313490408
MAPLE SYRUP URINE DISEASE	0.000545554	0.05362943313490408
ARGININEMIA	0.000545554	0.05362943313490408
HEREDITARY FOLATE MALABSORPTION	0.000545554	0.05362943313490408
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.05362943313490408
ATELOSTEOGENESIS TYPE III	0.000545554	0.05362943313490408
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.05362943313490408
20Q11.2 MICRODELETION SYNDROME	0.000545554	0.05362943313490408
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.000545554	0.05362943313490408
ABLEPHARON MACROSTOMIA SYNDROME	0.000545554	0.05362943313490408
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.05362943313490408
PFEIFFER SYNDROME TYPE 2	0.000545554	0.05362943313490408
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.05362943313490408
CONGENITAL HYPOTHYROIDISM	0.000545554	0.05362943313490408
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.000545554	0.05362943313490408
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.000545554	0.05362943313490408
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.05362943313490408
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.05362943313490408
ALG6-CDG	0.000545554	0.05362943313490408
CRANIOPHARYNGIOMA	0.000545554	0.05362943313490408
WYBURN-MASON SYNDROME	0.000545554	0.05362943313490408
PALLISTER-HALL SYNDROME	0.000545554	0.05362943313490408
SCHIZENCEPHALY	0.000545554	0.05362943313490408
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.05362943313490408
GRISCELLI SYNDROME, TYPE 1	0.000545554	0.05362943313490408
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.05362943313490408
SYNDROMIC DIARRHEA	0.000545554	0.05362943313490408
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.05362943313490408
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000545554	0.05362943313490408
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.05362943313490408
KEUTEL SYNDROME	0.000545554	0.05362943313490408
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.000545554	0.05362943313490408
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000545554	0.05362943313490408
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.05362943313490408
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.05362943313490408
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.05362943313490408
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.05362943313490408
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.000545554	0.05362943313490408
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.000545554	0.05362943313490408
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.000545554	0.05362943313490408
JOUBERT SYNDROME 26	0.000545554	0.05362943313490408
JOUBERT SYNDROME 25	0.000545554	0.05362943313490408
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.05362943313490408
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000545554	0.05362943313490408
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.05362943313490408
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.05362943313490408
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.05362943313490408
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.05362943313490408
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.05362943313490408
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.05362943313490408
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000545554	0.05362943313490408
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000545554	0.05362943313490408
SENIOR-LOKEN SYNDROME 9	0.000545554	0.05362943313490408
NOONAN SYNDROME 2; NS2	0.000545554	0.05362943313490408
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.05362943313490408
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.05362943313490408
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.05362943313490408
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000545554	0.05362943313490408
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000545554	0.05362943313490408
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000545554	0.05362943313490408
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.05362943313490408
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000545554	0.05362943313490408
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000545554	0.05362943313490408
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.000545554	0.05362943313490408
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.000545554	0.05362943313490408
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.05362943313490408
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.05362943313490408
CHROMOSOME 16P13.2 DELETION SYNDROME	0.000545554	0.05362943313490408
LUSCAN-LUMISH SYNDROME; LLS	0.000545554	0.05362943313490408
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.05362943313490408
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000545554	0.05362943313490408
AU-KLINE SYNDROME; AUKS	0.000545554	0.05362943313490408
NOONAN SYNDROME 9; NS9	0.000545554	0.05362943313490408
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000545554	0.05362943313490408
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000545554	0.05362943313490408
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.000545554	0.05362943313490408
HURLER SYNDROME	0.000545554	0.05362943313490408
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.05362943313490408
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000545554	0.05362943313490408
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.000545554	0.05362943313490408
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000545554	0.05362943313490408
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.000545554	0.05362943313490408
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.05362943313490408
CATEL-MANZKE SYNDROME; CATMANS	0.000545554	0.05362943313490408
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000545554	0.05362943313490408
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.05362943313490408
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000545554	0.05362943313490408
LISSENCEPHALY 1; LIS1	0.000545554	0.05362943313490408
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.05362943313490408
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.05362943313490408
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.05362943313490408
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000545554	0.05362943313490408
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.05362943313490408
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.05362943313490408
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.000545554	0.05362943313490408
CHOPS SYNDROME; CHOPS	0.000545554	0.05362943313490408
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000545554	0.05362943313490408
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.000545554	0.05362943313490408
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.05362943313490408
PHACE ASSOCIATION	0.000545554	0.05362943313490408
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000545554	0.05362943313490408
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000545554	0.05362943313490408
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.05362943313490408
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.05362943313490408
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.000545554	0.05362943313490408
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.05362943313490408
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000545554	0.05362943313490408
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000545554	0.05362943313490408
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.000545554	0.05362943313490408
SOTOS SYNDROME	0.000545554	0.05362943313490408
JOUBERT SYNDROME 30; JBTS30	0.000545554	0.05362943313490408
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.000545554	0.05362943313490408
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000545554	0.05362943313490408
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.05362943313490408
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.05362943313490408
MECKEL SYNDROME 13; MKS13	0.000545554	0.05362943313490408
GABRIELE-DE VRIES SYNDROME; GADEVS	0.000545554	0.05362943313490408
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.000545554	0.05362943313490408
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.05362943313490408
RAHMAN SYNDROME	0.000545554	0.05362943313490408
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000545554	0.05362943313490408
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.000545554	0.05362943313490408
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.000545554	0.05362943313490408
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.000545554	0.05362943313490408
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.000545554	0.05362943313490408
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.000545554	0.05362943313490408
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000545554	0.05362943313490408
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.05362943313490408
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000545554	0.05362943313490408
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.000545554	0.05362943313490408
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.000545554	0.05362943313490408
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.000545554	0.05362943313490408
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.000545554	0.05362943313490408
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.05362943313490408
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.05362943313490408
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000545554	0.05362943313490408
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.05362943313490408
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.05362943313490408
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.05362943313490408
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.05362943313490408
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.05362943313490408
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.05362943313490408
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000545554	0.05362943313490408
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.05362943313490408
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.000545554	0.05362943313490408
GRACILE BONE DYSPLASIA; GCLEB	0.000545554	0.05362943313490408
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.000545554	0.05362943313490408
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000545554	0.05362943313490408
JOUBERT SYNDROME 28	0.000545554	0.05362943313490408
JOUBERT SYNDROME 27	0.000545554	0.05362943313490408
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000545554	0.05362943313490408
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.000545554	0.05362943313490408
MEIER-GORLIN SYNDROME 7	0.000545554	0.05362943313490408
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000545554	0.05362943313490408
MIRAGE SYNDROME; MIRAGE	0.000545554	0.05362943313490408
MUENKE SYNDROME	0.000545554	0.05362943313490408
CDAGS SYNDROME	0.000545554	0.05362943313490408
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.000545554	0.05362943313490408
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.000545554	0.05362943313490408
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.000545554	0.05362943313490408
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000545554	0.05362943313490408
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.05362943313490408
HAREL-YOON SYNDROME; HAYOS	0.000545554	0.05362943313490408
SHASHI-PENA SYNDROME; SHAPNS	0.000545554	0.05362943313490408
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.000545554	0.05362943313490408
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000545554	0.05362943313490408
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.000545554	0.05362943313490408
IMMUNODEFICIENCY 49; IMD49	0.000545554	0.05362943313490408
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.000545554	0.05362943313490408
CURRY-JONES SYNDROME	0.000545554	0.05362943313490408
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.05362943313490408
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.000545554	0.05362943313490408
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000545554	0.05362943313490408
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.05362943313490408
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.000545554	0.05362943313490408
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.05362943313490408
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.05362943313490408
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000545554	0.05362943313490408
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.05362943313490408
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.05362943313490408
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000545554	0.05362943313490408
JOUBERT SYNDROME 15	0.000545554	0.05362943313490408
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000545554	0.05362943313490408
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000545554	0.05362943313490408
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.05362943313490408
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.05362943313490408
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000545554	0.05362943313490408
JOUBERT SYNDROME 6	0.000545554	0.05362943313490408
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.000545554	0.05362943313490408
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.05362943313490408
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.05362943313490408
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000545554	0.05362943313490408
HOLOPROSENCEPHALY 7	0.000545554	0.05362943313490408
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.000545554	0.05362943313490408
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.05362943313490408
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.000545554	0.05362943313490408
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.000545554	0.05362943313490408
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.05362943313490408
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.05362943313490408
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000545554	0.05362943313490408
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000545554	0.05362943313490408
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.05362943313490408
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000545554	0.05362943313490408
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.000545554	0.05362943313490408
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.000545554	0.05362943313490408
PONTINE TEGMENTAL CAP DYSPLASIA	0.000545554	0.05362943313490408
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.05362943313490408
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.000545554	0.05362943313490408
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.05362943313490408
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000545554	0.05362943313490408
COFFIN-SIRIS SYNDROME 2; CSS2	0.000545554	0.05362943313490408
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.000545554	0.05362943313490408
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000545554	0.05362943313490408
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000545554	0.05362943313490408
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000545554	0.05362943313490408
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000545554	0.05362943313490408
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000545554	0.05362943313490408
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.05362943313490408
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.000545554	0.05362943313490408
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.000545554	0.05362943313490408
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.05362943313490408
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.05362943313490408
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.05362943313490408
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.000545554	0.05362943313490408
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.000545554	0.05362943313490408
JOUBERT SYNDROME 8	0.000545554	0.05362943313490408
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.05362943313490408
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.000545554	0.05362943313490408
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.05362943313490408
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.05362943313490408
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.000545554	0.05362943313490408
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000545554	0.05362943313490408
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000545554	0.05362943313490408
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000545554	0.05362943313490408
JOUBERT SYNDROME 7	0.000545554	0.05362943313490408
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.05362943313490408
GABA-TRANSAMINASE DEFICIENCY	0.000545554	0.05362943313490408
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.05362943313490408
ROIFMAN-CHITAYAT SYNDROME	0.000545554	0.05362943313490408
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.05362943313490408
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.05362943313490408
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.05362943313490408
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.05362943313490408
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.000545554	0.05362943313490408
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.05362943313490408
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.000545554	0.05362943313490408
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000545554	0.05362943313490408
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000545554	0.05362943313490408
PEROXISOME BIOGENESIS DISORDER 5B	0.000545554	0.05362943313490408
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.05362943313490408
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.000545554	0.05362943313490408
KAGAMI-OGATA SYNDROME	0.000545554	0.05362943313490408
CULLER-JONES SYNDROME; CJS	0.000545554	0.05362943313490408
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000545554	0.05362943313490408
XIA-GIBBS SYNDROME	0.000545554	0.05362943313490408
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000545554	0.05362943313490408
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.05362943313490408
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.05362943313490408
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000545554	0.05362943313490408
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000545554	0.05362943313490408
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.000545554	0.05362943313490408
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000545554	0.05362943313490408
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.05362943313490408
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.05362943313490408
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000545554	0.05362943313490408
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.05362943313490408
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.000545554	0.05362943313490408
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000545554	0.05362943313490408
JOUBERT SYNDROME 2	0.000545554	0.05362943313490408
HELSMOORTEL-VAN DER AA SYNDROME	0.000545554	0.05362943313490408
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.05362943313490408
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000545554	0.05362943313490408
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000545554	0.05362943313490408
BARDET-BIEDL SYNDROME 2	0.000545554	0.05362943313490408
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.05362943313490408
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.05362943313490408
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.05362943313490408
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.05362943313490408
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.05362943313490408
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.000545554	0.05362943313490408
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000545554	0.05362943313490408
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000545554	0.05362943313490408
NIEMANN-PICK DISEASE, TYPE C2	0.000545554	0.05362943313490408
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.000545554	0.05362943313490408
JOUBERT SYNDROME 21	0.000545554	0.05362943313490408
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.05362943313490408
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.05362943313490408
STEEL SYNDROME; STLS	0.000545554	0.05362943313490408
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.05362943313490408
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000545554	0.05362943313490408
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.05362943313490408
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000545554	0.05362943313490408
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.000545554	0.05362943313490408
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.000545554	0.05362943313490408
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.05362943313490408
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000545554	0.05362943313490408
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.05362943313490408
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000545554	0.05362943313490408
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.05362943313490408
FRIAS SYNDROME	0.000545554	0.05362943313490408
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000545554	0.05362943313490408
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.05362943313490408
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.05362943313490408
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000545554	0.05362943313490408
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.000545554	0.05362943313490408
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.05362943313490408
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000545554	0.05362943313490408
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.05362943313490408
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.05362943313490408
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000545554	0.05362943313490408
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000545554	0.05362943313490408
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.000545554	0.05362943313490408
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.000545554	0.05362943313490408
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.05362943313490408
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.000545554	0.05362943313490408
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000545554	0.05362943313490408
SCHAAF-YANG SYNDROME; SHFYNG	0.000545554	0.05362943313490408
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.05362943313490408
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.000545554	0.05362943313490408
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.000545554	0.05362943313490408
RITSCHER-SCHINZEL SYNDROME 1	0.000545554	0.05362943313490408
OGDEN SYNDROME	0.000545554	0.05362943313490408
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.05362943313490408
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000545554	0.05362943313490408
OTOFACIOCERVICAL SYNDROME	0.000545554	0.05362943313490408
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.05362943313490408
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.05362943313490408
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.000545554	0.05362943313490408
OROFACIODIGITAL SYNDROME TYPE 2	0.000545554	0.05362943313490408
W SYNDROME	0.000545554	0.05362943313490408
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.05362943313490408
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.000545554	0.05362943313490408
OCULOFACIOCARDIODENTAL SYNDROME	0.000545554	0.05362943313490408
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.05362943313490408
OROTIC ACIDURIA	0.000545554	0.05362943313490408
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.000545554	0.05362943313490408
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.05362943313490408
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.05362943313490408
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.000545554	0.05362943313490408
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.05362943313490408
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.05362943313490408
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05362943313490408
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.05362943313490408
ELEJALDE DISEASE	0.000545554	0.05362943313490408
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.05362943313490408
TARP SYNDROME	0.000545554	0.05362943313490408
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.05362943313490408
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.000545554	0.05362943313490408
NIEMANN-PICK DISEASE, TYPE A	0.000545554	0.05362943313490408
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.05362943313490408
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.05362943313490408
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000545554	0.05362943313490408
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.05362943313490408
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.000545554	0.05362943313490408
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.05362943313490408
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.05362943313490408
PELLAGRA-LIKE SYNDROME	0.000545554	0.05362943313490408
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.05362943313490408
CENTRAL BILATERAL MACROGYRIA	0.000545554	0.05362943313490408
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.05362943313490408
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.000545554	0.05362943313490408
SULFOCYSTEINURIA	0.000545554	0.05362943313490408
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000545554	0.05362943313490408
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.05362943313490408
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.05362943313490408
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.05362943313490408
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.05362943313490408
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.000545554	0.05362943313490408
USHER SYNDROME TYPE 1	0.000545554	0.05362943313490408
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.000545554	0.05362943313490408
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05362943313490408
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.000545554	0.05362943313490408
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.05362943313490408
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.05362943313490408
CITRULLINEMIA TYPE II	0.000545554	0.05362943313490408
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.05362943313490408
1Q21.1 MICRODUPLICATION SYNDROME	0.000545554	0.05362943313490408
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.05362943313490408
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000545554	0.05362943313490408
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.05362943313490408
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.05362943313490408
3MC SYNDROME 2	0.000545554	0.05362943313490408
N SYNDROME	0.000545554	0.05362943313490408
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.000545554	0.05362943313490408
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.000545554	0.05362943313490408
DISTAL 16P11.2 MICRODELETION SYNDROME	0.000545554	0.05362943313490408
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.05362943313490408
17Q12 MICRODELETION SYNDROME	0.000545554	0.05362943313490408
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.05362943313490408
1P21.3 MICRODELETION SYNDROME	0.000545554	0.05362943313490408
HEREDITARY OROTIC ACIDURIA	0.000545554	0.05362943313490408
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.000545554	0.05362943313490408
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.05362943313490408
GAUCHER DISEASE, TYPE II	0.000545554	0.05362943313490408
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.05362943313490408
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.05362943313490408
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.000545554	0.05362943313490408
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000545554	0.05362943313490408
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.000545554	0.05362943313490408
HARTNUP DISORDER	0.000545554	0.05362943313490408
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.000545554	0.05362943313490408
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.05362943313490408
ISOLATED PLAGIOCEPHALY	0.000545554	0.05362943313490408
PROPIONIC ACIDEMIA	0.000545554	0.05362943313490408
FUCOSIDOSIS	0.000545554	0.05362943313490408
WILSON-TURNER SYNDROME	0.000545554	0.05362943313490408
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.000545554	0.05362943313490408
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.05362943313490408
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.05362943313490408
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.000545554	0.05362943313490408
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.05362943313490408
DYSTONIA-APHONIA SYNDROME	0.000545554	0.05362943313490408
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.000545554	0.05362943313490408
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.000545554	0.05362943313490408
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.000545554	0.05362943313490408
MEND SYNDROME	0.000545554	0.05362943313490408
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.05362943313490408
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.05362943313490408
FOLATE MALABSORPTION, HEREDITARY	0.000545554	0.05362943313490408
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.05362943313490408
PRADER-WILLI-LIKE SYNDROME	0.000545554	0.05362943313490408
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.05362943313490408
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05362943313490408
GRISCELLI SYNDROME	0.000545554	0.05362943313490408
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.000545554	0.05362943313490408
HYPERPROLINEMIA, TYPE I	0.000545554	0.05362943313490408
WEAVER SYNDROME	0.000545554	0.05362943313490408
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.000545554	0.05362943313490408
SEVERE CANAVAN DISEASE	0.000545554	0.05362943313490408
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.05362943313490408
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.05362943313490408
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.05362943313490408
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.05362943313490408
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.000545554	0.05362943313490408
SENIOR-LOKEN SYNDROME	0.000545554	0.05362943313490408
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.000545554	0.05362943313490408
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.05362943313490408
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.05362943313490408
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000545554	0.05362943313490408
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.000545554	0.05362943313490408
JAWAD SYNDROME	0.000545554	0.05362943313490408
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.000545554	0.05362943313490408
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.000545554	0.05362943313490408
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.05362943313490408
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.05362943313490408
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.05362943313490408
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.000545554	0.05362943313490408
LANDAU-KLEFFNER SYNDROME	0.000545554	0.05362943313490408
KETOADIPICACIDURIA	0.000545554	0.05362943313490408
SRD5A3-CDG	0.000545554	0.05362943313490408
RICHARDS-RUNDLE SYNDROME; RRNS	0.000545554	0.05362943313490408
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.05362943313490408
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.000545554	0.05362943313490408
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.000545554	0.05362943313490408
ARIMA SYNDROME	0.000545554	0.05362943313490408
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.000545554	0.05362943313490408
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.000545554	0.05362943313490408
FARBER DISEASE	0.000545554	0.05362943313490408
ARTERIAL TORTUOSITY SYNDROME	0.000545554	0.05362943313490408
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.000545554	0.05362943313490408
PERIPHERAL HYPOTHYROIDISM	0.000545554	0.05362943313490408
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.000545554	0.05362943313490408
PRIMARY CONGENITAL HYPOTHYROIDISM	0.000545554	0.05362943313490408
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.000545554	0.05362943313490408
WAISMAN SYNDROME; WSMN	0.000545554	0.05362943313490408
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.000545554	0.05362943313490408
TARP SYNDROME; TARPS	0.000545554	0.05362943313490408
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000545554	0.05362943313490408
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.05362943313490408
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000545554	0.05362943313490408
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.05362943313490408
POPOV-CHANG SYNDROME; POPCHAS	0.000545554	0.05362943313490408
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.000545554	0.05362943313490408
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.000545554	0.05362943313490408
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000545554	0.05362943313490408
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000545554	0.05362943313490408
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.05362943313490408
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000545554	0.05362943313490408
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.000545554	0.05362943313490408
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000545554	0.05362943313490408
PERMANENT CONGENITAL HYPOTHYROIDISM	0.000545554	0.05362943313490408
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000545554	0.05362943313490408
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.05362943313490408
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05362943313490408
MENTAL RETARDATION, X-LINKED 9	0.000545554	0.05362943313490408
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.000545554	0.05362943313490408
TRANSALDOLASE DEFICIENCY	0.000545554	0.05362943313490408
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.05362943313490408
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.05362943313490408
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.05362943313490408
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.000545554	0.05362943313490408
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000545554	0.05362943313490408
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000545554	0.05362943313490408
NOONAN SYNDROME 11; NS11	0.000545554	0.05362943313490408
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.000545554	0.05362943313490408
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.000545554	0.05362943313490408
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000545554	0.05362943313490408
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.05362943313490408
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.000545554	0.05362943313490408
TIMOTHY SYNDROME; TS	0.000545554	0.05362943313490408
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.000545554	0.05362943313490408
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000545554	0.05362943313490408
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.000545554	0.05362943313490408
COFFIN-SIRIS SYNDROME 7; CSS7	0.000545554	0.05362943313490408
HYPEREKPLEXIA 4; HKPX4	0.000545554	0.05362943313490408
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.000545554	0.05362943313490408
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.000545554	0.05362943313490408
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000545554	0.05362943313490408
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.05362943313490408
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.000545554	0.05362943313490408
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.000545554	0.05362943313490408
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000545554	0.05362943313490408
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.000545554	0.05362943313490408
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.000545554	0.05362943313490408
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000545554	0.05362943313490408
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.05362943313490408
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.05362943313490408
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.000545554	0.05362943313490408
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.05362943313490408
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.000545554	0.05362943313490408
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.05362943313490408
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000545554	0.05362943313490408
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000545554	0.05362943313490408
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.05362943313490408
CHROMOSOME 2Q37 DELETION SYNDROME	0.000545554	0.05362943313490408
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.05362943313490408
CODAS SYNDROME	0.000545554	0.05362943313490408
BAND HETEROTOPIA; BH	0.000545554	0.05362943313490408
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.000545554	0.05362943313490408
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.000545554	0.05362943313490408
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.05362943313490408
AYMÉ-GRIPP SYNDROME	0.000545554	0.05362943313490408
CRANIOFRONTONASAL SYNDROME; CFNS	0.000545554	0.05362943313490408
CONGENITAL DISORDER OF GLYCOSYLATION	0.000545554	0.05362943313490408
EAST SYNDROME	0.000545554	0.05362943313490408
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.05362943313490408
COLE-CARPENTER SYNDROME	0.000545554	0.05362943313490408
FLOATING-HARBOR SYNDROME	0.000545554	0.05362943313490408
MENTAL RETARDATION, X-LINKED 72	0.000545554	0.05362943313490408
COWDEN SYNDROME	0.000545554	0.05362943313490408
ADULT-ONSET DYSTONIA-PARKINSONISM	0.000545554	0.05362943313490408
OCCIPITAL HORN SYNDROME	0.000545554	0.05362943313490408
TRISOMY 8Q	0.000545554	0.05362943313490408
EARLY MYOCLONIC ENCEPHALOPATHY	0.000545554	0.05362943313490408
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.05362943313490408
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000545554	0.05362943313490408
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.05362943313490408
ACROMELIC FRONTONASAL DYSPLASIA	0.000545554	0.05362943313490408
TEMTAMY SYNDROME	0.000545554	0.05362943313490408
GERODERMA OSTEODYSPLASTICA	0.000545554	0.05362943313490408
SPINOCEREBELLAR ATAXIA TYPE 29	0.000545554	0.05362943313490408
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.000545554	0.05362943313490408
RAYNAUD-CLAES SYNDROME; MRXSRC	0.000545554	0.05362943313490408
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.000545554	0.05362943313490408
HARTNUP DISEASE	0.000545554	0.05362943313490408
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.05362943313490408
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.000545554	0.05362943313490408
DONNAI-BARROW SYNDROME	0.000545554	0.05362943313490408
ZECHI-CEIDE SYNDROME	0.000545554	0.05362943313490408
611961 STEVENSON-CAREY SYNDROME	0.000545554	0.05362943313490408
HYDRANENCEPHALY	0.000545554	0.05362943313490408
WAARDENBURG-SHAH SYNDROME	0.000545554	0.05362943313490408
NEPHROGENIC DIABETES INSIPIDUS	0.000545554	0.05362943313490408
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.05362943313490408
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.05362943313490408
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000545554	0.05362943313490408
DYSKERATOSIS CONGENITA	0.000545554	0.05362943313490408
DISTAL TRISOMY 6P	0.000545554	0.05362943313490408
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.000545554	0.05362943313490408
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000545554	0.05362943313490408
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.000545554	0.05362943313490408
MENTAL RETARDATION, X-LINKED 103	0.000545554	0.05362943313490408
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.05362943313490408
MULTIPLE CARBOXYLASE DEFICIENCY	0.000545554	0.05362943313490408
MENTAL RETARDATION, X-LINKED 104; MRX104	0.000545554	0.05362943313490408
CINCA SYNDROME	0.000545554	0.05362943313490408
XQ21 MICRODELETION SYNDROME	0.000545554	0.05362943313490408
MENTAL RETARDATION, X-LINKED 41	0.000545554	0.05362943313490408
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.05362943313490408
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000545554	0.05362943313490408
SHUKLA-VERNON SYNDROME; SHUVER	0.000545554	0.05362943313490408
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.05362943313490408
AURICULOCONDYLAR SYNDROME	0.000545554	0.05362943313490408
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.000545554	0.05362943313490408
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.05362943313490408
MEND SYNDROME; MEND	0.000545554	0.05362943313490408
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000545554	0.05362943313490408
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.05362943313490408
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.000545554	0.05362943313490408
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.000545554	0.05362943313490408
MENTAL RETARDATION, X-LINKED 98; MRX98	0.000545554	0.05362943313490408
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.000545554	0.05362943313490408
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.000545554	0.05362943313490408
DEXTROCARDIA	0.000545554	0.05362943313490408
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.05362943313490408
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000545554	0.05362943313490408
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.05362943313490408
MENTAL RETARDATION, X-LINKED 88	0.000545554	0.05362943313490408
MOSAIC TRISOMY 14	0.000545554	0.05362943313490408
MENTAL RETARDATION, X-LINKED 90	0.000545554	0.05362943313490408
DISTAL TRISOMY 18Q	0.000545554	0.05362943313490408
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.05362943313490408
